var title_f39_22_40288="Coronary steal physiology";
var content_f39_22_40288=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Coronary steal physiology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 506px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In coronary-subclavian steal, severe stenosis or occlusion of the left subclavian artery proximal to the origin of a left internal mammary-to-coronary artery bypass graft may cause \"steal\" from the coronary graft to maintain perfusion to the arm via the left subclavian artery during upper extremity exercise.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40288=[""].join("\n");
var outline_f39_22_40288=null;
var title_f39_22_40289="Ultrasound fetal hydranencephaly";
var content_f39_22_40289=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Hydranencephaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 392px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial section of the fetal head.&nbsp;Except for the midlike falx, no brain structures are seen.&nbsp;They are replaced by cerebro-spinal fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40289=[""].join("\n");
var outline_f39_22_40289=null;
var title_f39_22_40290="Acne fulminans";
var content_f39_22_40290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne fulminans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This healthy adolescent with severe nodulocystic acne developed ulcerations and crusts shortly after starting oral 13-cisretinoic acid. Oral corticosteroids were added to his regimen and slowly tapered over 2 months.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40290=[""].join("\n");
var outline_f39_22_40290=null;
var title_f39_22_40291="ANLL FAB M2";
var content_f39_22_40291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute myeloid leukemia (AML FAB M2)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow aspirate from a patient with AML of the M2 variant. The blasts are slightly more mature than M1 blasts. The cytoplasm may contain multiple fine granules (red arrow) and Auer rods (black arrow). (Wright-Giemsa).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David S Rosenthal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40291=[""].join("\n");
var outline_f39_22_40291=null;
var title_f39_22_40292="Spontaneous bacterial peritonitis variants";
var content_f39_22_40292=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Spontaneous bacterial peritonitis variants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40292/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40292/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40292/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40292/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40292/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40292/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/22/40292/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intraabdominal surgically treatable source; it primarily occurs in patients with advanced cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The diagnosis is established by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ).",
"    </span>",
"   </p>",
"   <p>",
"    When",
"    faced with a patient who appears to have spontaneous bacterial peritonitis (SBP), the clinician should at least consider the possibility that the patient might have a surgically treatable source for the infection (eg, a ruptured peptic ulcer). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12296?source=see_link\">",
"     \"Diagnosis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .) This distinction is crucial because the mortality of secondary bacterial peritonitis in the presence of ascites approaches 100 percent, if treated only with antibiotics with no surgical intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/1\">",
"     1",
"    </a>",
"    ]. Conversely, if a patient with SBP receives an unnecessary exploratory laparotomy, the mortality is approximately 80 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/3\">",
"     3",
"    </a>",
"    ]. With appropriate antibiotic treatment of SBP, infection-related mortality approaches zero [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are three variants of SBP that are also \"spontaneous\" (ie, there is no surgically treatable source for the infection) (",
"    <a class=\"graphic graphic_table graphicRef77418 \" href=\"mobipreview.htm?8/18/8491\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Culture-negative neutrocytic ascites",
"     </li>",
"     <li>",
"      Monomicrobial non-neutrocytic bacterascites",
"     </li>",
"     <li>",
"      Polymicrobial bacterascites",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These variants are distinguished from classic SBP largely by ascitic fluid analysis (",
"    <a class=\"graphic graphic_table graphicRef77418 \" href=\"mobipreview.htm?8/18/8491\">",
"     table 1",
"    </a>",
"    ). Separate labeling of each of these variants may seem artificial, but probably has clinical relevance. Research efforts to explain the differences between these subgroups have led to improvements in culture technique and advancement in our understanding of the sequence of events that lead to ascitic fluid infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CULTURE-NEGATIVE NEUTROCYTIC ASCITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The phrase culture-negative neutrocytic ascites (CNNA) was proposed in 1984 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/6\">",
"     6",
"    </a>",
"    ]. This diagnosis was made when a patient had an elevated ascitic fluid absolute PMN count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    with a negative ascitic fluid culture (in the absence of antibiotic therapy or pancreatitis) and no evident intraabdominal surgically treatable source of infection. A PMN threshold of",
"    <span class=\"nowrap\">",
"     500/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    was initially used, but this was subsequently revised to",
"    <span class=\"nowrap\">",
"     250/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </span>",
"    Although a PMN count above",
"    <span class=\"nowrap\">",
"     100/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    is probably pathologic, there is enough error in the manual count and differential to justify a higher threshold. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12296?source=see_link\">",
"     \"Diagnosis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since the original publication, it has become apparent that a number of disorders other than SBP can produce a somewhat similar picture. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tuberculous peritonitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Malignancy-related ascites [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Any process that leads to death of cells (eg, lysing tumor cells) can activate complement or cytokines that can attract PMNs into the peritoneal cavity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, in the absence of an active bacterial infection, there is usually not a predominance of PMNs in these setting. In contrast, there is almost always a PMN predominance in SBP.",
"   </p>",
"   <p>",
"    One potential source of error is that hemorrhage into the ascitic fluid, as in a traumatic paracentesis, leads to red cell and white cell entry into the fluid. A corrected PMN count should be calculated if there is bloody fluid: one PMN is subtracted from the absolute PMN count for every 250 red",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/9\">",
"     9",
"    </a>",
"    ]. PMNs lyse rapidly, much more so than red cells. Thus, if the bleeding episode occurred prior to rather than during paracentesis, the PMNs that entered the fluid may have lysed and the corrected PMN count may be a negative number.",
"   </p>",
"   <p>",
"    Paracentesis should",
"    <strong>",
"     precede",
"    </strong>",
"    the initiation of antibiotic therapy. However, it has been our experience that patients are frequently inappropriately given one or more doses of a parenteral antibiotic before they undergo paracentesis. The potential impact of antimicrobial therapy on culture results was shown in a study of patients with SBP with culture-positive fluid prior to treatment: 86 percent of repeat ascitic fluid cultures grew no bacteria when fluid was obtained six hours after a single 2 g dose of intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Importance of culture technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within 10 years of the original publication on CNNA, it became clear from multiple studies that the inability of the culture to grow bacteria was largely due to insensitive culture technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/5,10\">",
"     5,10",
"    </a>",
"    ]. The older method of culture was based on the erroneous assumption that infected ascitic fluid was usually a high-colony-count, polymicrobial infection, as in surgical peritonitis. However, most ascitic fluid infections are \"spontaneous\" with a low-colony-count, and are monomicrobial similar to bacteremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/10\">",
"     10",
"    </a>",
"    ]. Culturing ascitic fluid as if it were blood (ie, bedside inoculation of ascitic fluid into blood culture bottles) has been shown to increase the culture-positivity of the ascitic fluid of patients with an ascitic fluid PMN count &ge;250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    (in the absence of prior antibiotic treatment, pancreatitis, tuberculous peritonitis, or malignancy-related ascites) from about 50 percent (with the conventional method) to approximately 80 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12296?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of spontaneous bacterial peritonitis\", section on 'Ascitic fluid analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The volume of fluid cultured also has a dramatic impact on the sensitivity of the culture in detecting bacterial growth. In one report, for example, inoculation of 10 or 20 mL of fluid into 100 mL blood culture bottles led to a much higher culture-positivity rate than a 1 mL inoculum (93 versus 53 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, in the care of the 20 percent of patients who have neutrocytic ascites and grow no bacteria have one or more of the following probably occurred:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unrecognized treatment (as is common in emergency departments) occurred with one or more doses of antibiotic.",
"     </li>",
"     <li>",
"      Culture technique was inadequate, with an inadequate volume of fluid in the inoculum.",
"     </li>",
"     <li>",
"      One of the other causes of culture-negative neutrocytic ascites took place (eg, hemorrhage into the fluid, tuberculous peritonitis, pancreatitis, and malignancy).",
"     </li>",
"     <li>",
"      SBP resolved spontaneously; in such patients, late paracentesis may be performed at a time when the bacterial count has been reduced below the threshold of detectability by our current culture techniques (",
"      <a class=\"graphic graphic_figure graphicRef56516 \" href=\"mobipreview.htm?0/22/366\">",
"       figure 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The short-term natural history of CNNA was assessed in a prospective study in which paracentesis was repeated within about eight hours of the initial tap and prior to initiation of antibiotic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/11\">",
"     11",
"    </a>",
"    ]. In 19 (66 percent) of 29 well characterized episodes of CNNA, the second culture was also negative with a falling PMN count in 18 (",
"    <a class=\"graphic graphic_figure graphicRef56516 \" href=\"mobipreview.htm?0/22/366\">",
"     figure 1",
"    </a>",
"    ). The follow-up culture grew bacteria in the remaining 10 who progressed to SBP.",
"   </p>",
"   <p>",
"    Similar conclusions were reached in another report that focused on 427 asymptomatic, patients with cirrhosis who underwent paracentesis as outpatients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/12\">",
"     12",
"    </a>",
"    ]. The authors observed spontaneous resolution (ie, without antibiotics) in four episodes in which the ascitic fluid neutrophil count was &ge;250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    but &lt;500",
"    <span class=\"nowrap\">",
"     cells/",
"    </span>",
"    mm",
"    <sup>",
"     3",
"    </sup>",
"    (one which one was culture positive).",
"   </p>",
"   <p>",
"    The observation that ascitic fluid infection may spontaneously resolve may explain the lower mortality of CNNA compared to SBP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/13\">",
"     13",
"    </a>",
"    ]. However, recognition of this phenomenon should not decrease the enthusiasm for empiric treatment of patients with an ascitic fluid PMN count &ge;250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These findings and our experience indicate that there is always an explanation for an elevated ascitic fluid PMN count. PMNs do not enter the ascitic fluid without a reason to be there. Spillover from the circulation is not an explanation, since patients with profound peripheral leukocytosis do not have PMNs in their ascitic fluid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MONOMICROBIAL NON-NEUTROCYTIC BACTERASCITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monomicrobial non-neutrocytic bacterascites (MNB) usually represents the colonization phase of ascitic fluid infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/15\">",
"     15",
"    </a>",
"    ]. The flora are similar to those of SBP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/15\">",
"     15",
"    </a>",
"    ]. MNB may progress to SBP or, in 62 to 86 percent of cases, resolve spontaneously (",
"    <a class=\"graphic graphic_figure graphicRef56516 \" href=\"mobipreview.htm?0/22/366\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An increase in the number of paracenteses that is currently being performed has led to enhanced recognition of this variant. The high spontaneous resolution rate suggests that the clinician may not need to know about all colonization episodes. A study in which routine bacterial cultures were performed at the time of therapeutic paracentesis in outpatients without symptoms of infection demonstrated that 2 percent of patients had bacterascites comprised of skin flora that were probably contaminants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/12\">",
"     12",
"    </a>",
"    ]. In the absence of signs or symptoms of infection, bacterial cultures are probably not necessary when performing a therapeutic paracentesis.",
"   </p>",
"   <p>",
"    The symptoms of the patient help predict who will progress to SBP and who will resolve the colonization. Patients destined to progress to SBP in general have fever at the time of the initial tap; in contrast, patients destined to resolve the colonization are usually asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Progression from MNB to SBP can occur very rapidly. One study documented a 50 to 170-fold rise in PMN count within 40 to 70 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     POLYMICROBIAL BACTERASCITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymicrobial bacterascites is caused by a traumatic paracentesis in which the bowel is entered by the paracentesis needle and bacteria leak, usually transiently, from the gut into the fluid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40292/abstract/17\">",
"     17",
"    </a>",
"    ]. This complication is recognized when air or frank stool is aspirated during attempted paracentesis or when multiple bacteria are seen on Gram stain or grow on culture of non-neutrocytic ascites (ie, PMN count &lt;250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ).",
"    </span>",
"    It occurs once in approximately 1000 paracenteses, usually occurs when the operator is inexperienced, the needle is placed too close to a surgical scar (with bowel adherent to the abdominal wall), or ileus is present. We have never encountered an episode of this variant in which surgical intervention was required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H117709505\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intraabdominal surgically treatable source; it primarily occurs in patients with advanced cirrhosis.",
"     </li>",
"     <li>",
"      There are three variants of SBP, which are distinguished from classic SBP largely by ascitic fluid analysis (",
"      <a class=\"graphic graphic_table graphicRef77418 \" href=\"mobipreview.htm?8/18/8491\">",
"       table 1",
"      </a>",
"      ). It is important to recognize these variants in at-risk patients who do not fulfill classical definitions of SBP.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H353092752\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/1\">",
"      Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990; 98:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/2\">",
"      Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49:2087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/3\">",
"      Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/4\">",
"      Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991; 100:1737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/5\">",
"      Sheer TA, Runyon BA. Spontaneous bacterial peritonitis. Dig Dis 2005; 23:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/6\">",
"      Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984; 4:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/7\">",
"      Hillebrand DJ, Runyon BA, Yasmineh WG, Rynders GP. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology 1996; 24:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/8\">",
"      Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/9\">",
"      Hoefs JC. Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease. Hepatology 1981; 1:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/10\">",
"      Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95:1351.",
"     </a>",
"    </li>",
"    <li>",
"     McHutchison JG, Runyon BA. Spontaneous bacterial peritonitis. In: Gastrointestinal and Hepatic Infections, Surawicz CM, Owen RL (Eds), WB Saunders, Philadelphia 1994. p.455.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/12\">",
"      Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003; 37:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/13\">",
"      Pelletier G, Salmon D, Ink O, et al. Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis. J Hepatol 1990; 10:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/14\">",
"      Antillon MR, Runyon BA. Effect of marked peripheral leukocytosis on the leukocyte count in ascites. Arch Intern Med 1991; 151:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/15\">",
"      Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology 1990; 12:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/16\">",
"      Pelletier G, Lesur G, Ink O, et al. Asymptomatic bacterascites: is it spontaneous bacterial peritonitis? Hepatology 1991; 14:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40292/abstract/17\">",
"      Runyon BA, Hoefs JC, Canawati HN. Polymicrobial bacterascites. A unique entity in the spectrum of infected ascitic fluid. Arch Intern Med 1986; 146:2173.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1250 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-89.218.100.194-EFEE8658EB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40292=[""].join("\n");
var outline_f39_22_40292=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H117709505\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CULTURE-NEGATIVE NEUTROCYTIC ASCITES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Importance of culture technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MONOMICROBIAL NON-NEUTROCYTIC BACTERASCITES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      POLYMICROBIAL BACTERASCITES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H117709505\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H353092752\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1250\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1250|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/22/366\" title=\"figure 1\">",
"      Types ascitic fluid infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1250|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/18/8491\" title=\"table 1\">",
"      SBP variants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12296?source=related_link\">",
"      Diagnosis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4121?source=related_link\">",
"      Treatment and prophylaxis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_22_40293="Colorectal cancer treatment; metastatic cancer";
var content_f39_22_40293=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/22/40293/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40293/contributors\" id=\"au1707\">",
"       Axel Grothey, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40293/contributors\" id=\"au5173\">",
"       Jeffrey W Clark, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/22/40293/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40293/contributors\" id=\"se4549\">",
"       Kenneth K Tanabe, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/22/40293/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40293/contributors\" id=\"de5563\">",
"       Diane MF Savarese, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/22/40293?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      COLORECTAL CANCER OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Colon and rectal cancer are cancers that involve the lowest part of the digestive system: the large intestine and the rectum (",
"     <a class=\"graphic graphic_figure graphicRef58531 \" href=\"mobipreview.htm?12/60/13250\">",
"      figure 1",
"     </a>",
"     ). Despite early diagnosis and treatment, cancers involving the colon or rectum (colorectal cancer) can reappear at a later time, even if the cancer was entirely removed during the initial treatment. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/0/6148?source=see_link\">",
"      \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Reappearance of the colorectal cancer after initial curative therapy is referred to as a recurrence or a relapse. A colorectal cancer recurrence can be either local (confined to the large intestine or nearby tissues) or at a distant site. When the recurrence develops at a site away from the colon or rectum, it is called a metastasis.",
"    </p>",
"    <p>",
"     In other cases, a colorectal cancer will have already spread to distant sites by the time it is diagnosed. This is also referred to as metastatic (stage IV) colorectal cancer.",
"    </p>",
"    <p>",
"     Cure is not possible for most patients with metastatic colorectal cancer, although some patients who have limited involvement (particularly restricted to the liver or lung) can be cured with surgery. For others, chemotherapy is the most appropriate option. Chemotherapy does not cure metastatic colorectal cancer, but it can improve symptoms and prolong life.",
"    </p>",
"    <p>",
"     This article will discuss management of patients with metastatic colorectal cancer. Treatment for localized colon cancer and localized rectal cancer is discussed elsewhere. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/0/6148?source=see_link\">",
"      \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      TREATMENT FOR RESECTABLE METASTATIC COLORECTAL CANCER",
"     </span>",
"    </p>",
"    <p>",
"     Sometimes surgery is an option for a person whose colorectal cancer has spread in a limited way outside of the intestine to an area such as the liver. Up to 30 percent of people may be cured if metastases in the liver can be completely removed (the medical term for this is \"resected\") [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/1\">",
"      1",
"     </a>",
"     ]. In order for surgery to be considered, there must be no evidence of cancer outside of the liver, and there must be an adequate amount of normal liver left behind after the resection to sustain life.",
"    </p>",
"    <p>",
"     There is controversy and variability about what is considered \"resectable\" versus \"nonresectable\" metastatic disease in the liver. If at all possible, patients should request a consultation with an experienced liver surgeon or surgical oncologist (a surgeon with expertise in the treatment of cancer) before deciding upon a treatment plan.",
"    </p>",
"    <p>",
"     Chemotherapy may be recommended before surgery in some cases, even if the metastatic disease appears confined to the liver. This approach may help a person who is a borderline candidate for surgery (because of the size or location of the tumors) to have successful surgery after the colorectal cancer metastases have been reduced in size by the chemotherapy [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/2\">",
"      2",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     If surgical removal of the liver metastases is successful, additional chemotherapy is often recommended after surgery [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/3\">",
"      3",
"     </a>",
"     ]. (See",
"     <a class=\"local\" href=\"#H11\">",
"      'First-line chemotherapy for metastatic colorectal cancer'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     At some institutions, the chemotherapy is given directly into the liver (an approach called hepatic intraarterial chemotherapy) with or without additional chemotherapy given into the veins (intravenous chemotherapy) [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/4\">",
"      4",
"     </a>",
"     ]. However, it is unclear if this approach is better than intravenous chemotherapy alone; the most commonly used approach is intravenous chemotherapy.",
"    </p>",
"    <p>",
"     Surgical treatment may also be considered for a patient with a limited amount of metastatic disease in the lung.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CHEMOTHERAPY FOR UNRESECTABLE COLORECTAL CANCER",
"     </span>",
"    </p>",
"    <p>",
"     As noted above, surgery is the only way to cure metastatic colorectal cancer. In most cases, surgery is not possible, and chemotherapy is recommended to reduce symptoms and prolong survival. Although chemotherapy provides meaningful improvements in survival, it is not possible to cure metastatic colorectal cancer with chemotherapy alone.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Continuum of care concept",
"     </span>",
"     &nbsp;&mdash;&nbsp;With most types of incurable cancer (other than metastatic colorectal cancer), individual chemotherapy drugs or regimens are given continuously until the cancer stops responding to that drug or regimen, and then an entirely new regimen (termed \"second-line therapy\") may be tried.",
"    </p>",
"    <p>",
"     The situation is different with metastatic colorectal cancer because there are many active drugs that can be combined in a number of ways. In addition, treatment-related side effects may be lessened by limiting the number of doses of certain drugs. Thus, instead of giving the first-line regimen until the tumor progresses, treatment is often individualized.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Specific chemotherapy drugs may be given, stopped, and then restarted at a later time, sometimes in combination with other chemotherapy drugs.",
"      </li>",
"      <li>",
"       Periods of aggressive chemotherapy may be interspersed with periods of \"maintenance\" chemotherapy, allowing the patient to have the greatest possible quality of life while minimizing side effects.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     This has been referred to as the \"continuum of care\" approach to treatment of metastatic colorectal cancer.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Conventional chemotherapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;The conventional chemotherapy drugs used to treat metastatic colorectal cancer include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       5-fluorouracil (abbreviated FU), which is usually given into the vein with a second drug called leucovorin, which enhances its activity",
"      </li>",
"      <li>",
"       Orally active FU-like drugs, such as capecitabine (Xeloda)",
"      </li>",
"      <li>",
"       Oxaliplatin (Eloxatin), which is given intravenously",
"      </li>",
"      <li>",
"       Irinotecan (Camptosar), also given intravenously",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     These drugs work by interfering with the ability of rapidly growing cells (like cancer cells) to divide or reproduce themselves. Because most of an adult's normal cells are not actively growing, they are less affected by chemotherapy, with the exception of bone marrow (where the blood cells are produced), the hair, and the lining of the gastrointestinal tract. Effects of chemotherapy on these and other normal tissues cause side effects during treatment. (See",
"     <a class=\"local\" href=\"#H20\">",
"      'Colorectal cancer chemotherapy side effects'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Targeted chemotherapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Three other drugs that are active against metastatic colorectal cancer work by a different mechanism. These are referred to as \"targeted chemotherapy agents\" since they are antibodies (a type of protein) that work to inhibit a specific protein that is important for the growth",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     survival of colon cancer cells.",
"    </p>",
"    <p>",
"     Because targeted chemotherapy does not directly interfere with rapidly dividing cells, they do not have the usual side effects of conventional chemotherapy. However, targeted chemotherapy has other unique side effects, which are described in detail below. (See",
"     <a class=\"local\" href=\"#H20\">",
"      'Colorectal cancer chemotherapy side effects'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     Currently available targeted chemotherapy includes:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Bevacizumab (Avastin)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Bevacizumab binds to a protein called vascular endothelial growth factor (VEGF). VEGF is involved in the development of a blood supply within a growing cancer; this blood supply is essential for the tumor to grow and spread. Bevacizumab enhances the antitumor effect of other chemotherapy drugs. Bevacizumab is not effective when given by itself, but is generally given in combination with other drugs, such as oxaliplatin and irinotecan (see below).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H63491241\">",
"     <span class=\"h3\">",
"      Aflibercept (Zaltrap)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Intravenous aflibercept represents another method of interfering with a tumor&rsquo;s blood supply; it is a fusion protein that acts by &ldquo;trapping&rdquo; VEGF and preventing it from activating its receptors on the tumor cells. In the United States, aflibercept is approved, in combination with irinotecan-based chemotherapy, for patients whose tumors have progressed while receiving an oxaliplatin-containing chemotherapy regimen, with or without bevacizumab.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1142161329\">",
"     <span class=\"h3\">",
"      Regorafenib (Stivarga)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Regorafenib is a pill form of a drug that blocks several VEGF receptors as well as other proteins referred to as kinases. In the United States, regorafenib is approved as a single agent for the treatment of patients who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens as well as other targeted therapies.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Cetuximab (Erbitux)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cetuximab targets a different protein, the epidermal growth factor receptor (EGFR), which is found in about 80 percent of colorectal cancers. Erbitux&reg; is effective even if EGFR is not found in an individual tumor.",
"    </p>",
"    <p>",
"     Cetuximab does not work for all patients. It depends on whether or not the tumor has a specific abnormality (a mutation in a gene called K-ras).",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If the tumor has a K-ras mutation, cetuximab does not work.",
"      </li>",
"      <li>",
"       If the tumor does not have a K-ras mutation, cetuximab does work (ie, it is effective).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Unlike bevacizumab, cetuximab is active when given alone or in combination with other drugs, like irinotecan.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Panitumumab (Vectibix)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Like cetuximab, panitumumab also targets the EGFR. Like cetuximab, it is effective only for tumors that do not have a specific mutation in the K-ras gene.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Monitoring during treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;A person's response to chemotherapy is monitored with periodic X-ray studies (such as CT scans) every six to eight weeks during therapy. In addition, blood levels of a tumor marker called carcinoembryonic antigen (CEA) are generally measured every one to three months during therapy. CEA levels are typically high in people with advanced colorectal cancer; persistently rising CEA levels suggest that disease is progressing and a change in therapy is warranted.",
"    </p>",
"    <p>",
"     However, a rising CEA alone is not sufficient evidence to prompt a change in treatment. Disease progression should be confirmed with radiographic testing (eg, CT scan) or a biopsy before changing treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      FIRST-LINE CHEMOTHERAPY FOR METASTATIC COLORECTAL CANCER",
"     </span>",
"    </p>",
"    <p>",
"     Conventional chemotherapy drugs and targeted agents are generally used in combination for people with newly diagnosed, previously untreated metastatic colorectal cancer. Many different combinations have been developed and may be recommended for initial (first-line) treatment. The following sections will review the choices for the chemotherapy \"backbone\". Following this is a discussion of adding targeted chemotherapy agents, such as bevacizumab, to this backbone.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      FOLFOX, FOLFIRI, and XELOX",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several combination chemotherapy regimens may be considered for the initial treatment of metastatic colorectal cancer [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/5,6\">",
"      5,6",
"     </a>",
"     ]. Each of these regimens consists of two or three drugs, used together in a specific way:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Oxaliplatin plus FU and leucovorin (referred to as FOLFOX)",
"      </li>",
"      <li>",
"       Irinotecan plus FU and leucovorin (referred to as FOLFIRI)",
"      </li>",
"      <li>",
"       Oxaliplatin plus capecitabine (referred to as XELOX or CAPOX)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     With FOLFOX and FOLFIRI, the oxaliplatin or irinotecan are typically given into a vein (intravenously) all at once on the first day of treatment (day 1). The leucovorin and 5-FU are given IV on two consecutive days (days 1 and 2). Both regimens require that patients have a central venous access catheter (often termed a \"port\"), which is surgically inserted into one of the large blood vessels in the chest, and a portable chemotherapy pump at home (referred to as a home infusion pump). This pump is actually very small, and it fits into a pack that can be worn around the waist.",
"    </p>",
"    <p>",
"     Both FOLFIRI and FOLFOX result in similar outcomes when used as first-line therapy [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/5,6\">",
"      5,6",
"     </a>",
"     ]; the choice between them is often based upon expected side effects (see",
"     <a class=\"local\" href=\"#H20\">",
"      'Colorectal cancer chemotherapy side effects'",
"     </a>",
"     below). In the United States, patients are typically offered FOLFOX as the first-line regimen, with FOLFIRI reserved as a second-line treatment unless there are coexisting medical conditions (such as burning pain in the",
"     <span class=\"nowrap\">",
"      hands/feet,",
"     </span>",
"     called neuropathy) that might favor the initial use of FOLFIRI.",
"    </p>",
"    <p>",
"     With XELOX, the oral drug capecitabine (Xeloda&reg;) is given, along with intravenous oxaliplatin. This regimen is more convenient for the patient because it does not require a home infusion pump. The oxaliplatin is usually administered through a central venous line because it causes pain when administered into an arm vein.",
"    </p>",
"    <p>",
"     XELOX is probably as effective as FOLFOX for first-line treatment. However, some side effects (including diarrhea and hand-foot syndrome [redness, tenderness, and peeling of the skin of the palms and soles of the feet]) may be more pronounced with XELOX.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      How long is the first-line regimen recommended?",
"     </span>",
"     &nbsp;&mdash;&nbsp;The optimal duration of initial FOLFOX or XELOX is controversial.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If a person is responding well and has no severe or bothersome side effects, it is reasonable to continue the regimen until the tumor progresses.",
"      </li>",
"      <li>",
"       Another acceptable approach is to give three or four months of FOLFOX or XELOX, and then switch to \"maintenance chemotherapy\" with FU plus leucovorin or capecitabine. The oxaliplatin would be restarted at the time of disease progression. This regimen may delay the development of oxaliplatin-related neuropathy.",
"      </li>",
"      <li>",
"       If a patient develops a severe neuropathy during treatment with FOLFOX or XELOX, oxaliplatin may need to be withdrawn, at least temporarily, to allow the neuropathy to resolve. During this time, maintenance chemotherapy with 5-FU and leucovorin or capecitabine alone may be substituted, or a different chemotherapy regimen (eg, FOLFIRI) could be considered. (See",
"       <a class=\"local\" href=\"#H17\">",
"        'Second-line treatment of metastatic colorectal cancer'",
"       </a>",
"       below.) The risk associated with a complete break in chemotherapy in this setting is also addressed below. (See",
"       <a class=\"local\" href=\"#H14\">",
"        'Can I take a break from chemotherapy?'",
"       </a>",
"       below.)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The optimal duration of treatment with FOLFIRI is not clear. Patients who initially take FOLFIRI usually require a change in treatment because of disease progression, rather than side effects.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Can I take a break from chemotherapy?",
"     </span>",
"     &nbsp;&mdash;&nbsp;As noted above, a temporary discontinuation of oxaliplatin could be considered after three to four months of FOLFOX or XELOX therapy if the colorectal cancer has responded to treatment, there are no cancer-related symptoms, and tumor growth is not interfering with the function of other organs (eg, liver failure, bowel obstruction). However, a full break in therapy is usually not recommended because of the possibility that survival may be shortened. In most cases, continuation of at least some chemotherapy with 5-FU and leucovorin will be advised.",
"    </p>",
"    <p>",
"     If chemotherapy is stopped completely because of side effects or patient preference, close monitoring is recommended; this generally includes a CT scan every two months. If the colorectal cancer begins to progress, chemotherapy is generally restarted as soon as possible.",
"    </p>",
"    <p>",
"     There is less information about the potential harm of a complete treatment break with FOLFIRI. At least one study suggested that intermittent, rather than continuous, chemotherapy did not adversely impact survival.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Bevacizumab",
"     </span>",
"     &nbsp;&mdash;&nbsp;Adding bevacizumab to FOLFOX, XELOX, or FOLFIRI significantly increases the likelihood that the tumor will respond and prolongs survival compared with treatment without bevacizumab.",
"    </p>",
"    <p>",
"     In most cases, bevacizumab is recommended as a component of the first-line treatment of metastatic colorectal cancer, along with FOLFIRI, FOLFOX, or XELOX. However, the benefits of adding bevacizumab to these chemotherapy regimens must be balanced against the potentially serious side effects that can occur with this drug (eg, bleeding, blood clots). (See",
"     <a class=\"local\" href=\"#H7\">",
"      'Bevacizumab (Avastin)'",
"     </a>",
"     above.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Patients who cannot tolerate FOLFOX, XELOX, or FOLFIRI",
"     </span>",
"     &nbsp;&mdash;&nbsp;If a person cannot tolerate an aggressive chemotherapy regimen like FOLFOX, XELOX, or FOLFIRI because of their age, physical condition, or other medical problems, there are a few options:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Intravenous FU plus leucovorin, with or without bevacizumab is a reasonable and less toxic alternative. In the most commonly used variant of this regimen, the FU and leucovorin are given as an intravenous injection once weekly for six weeks, followed by a two-week break.",
"      </li>",
"      <li>",
"       Another alternative is capecitabine alone, which is taken in pill form twice daily for 14 days, followed by a seven-day break. Capecitabine is about as effective as is intravenous FU plus leucovorin.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     These regimens may be slightly less effective than FOLFOX or FOLFIRI, but they tend to be less toxic, and they do not require a central venous access catheter or home infusion pump.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      SECOND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Combination regimens",
"     </span>",
"     &nbsp;&mdash;&nbsp;If the colorectal cancer continues to grow despite chemotherapy or it begins to enlarge after an initial response to the first-line chemotherapy regimen, a different chemotherapy combination may be tried, as long as the patient is well enough to tolerate additional therapy.",
"    </p>",
"    <p>",
"     It is probably more important for the person to be exposed to",
"     <strong>",
"      ALL",
"     </strong>",
"     of the available chemotherapy drugs at some point during the course of treatment rather than to give the drugs in a specific order. This is because survival may be prolonged by second-line (as well as third-line) therapy.",
"    </p>",
"    <p>",
"     The choice of second-line treatment typically depends on what was given originally.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If FOLFOX (or XELOX) was the first-line regimen, patients are typically switched to FOLFIRI (or irinotecan alone). For subsequent therapy, if the tumor does not have the K-ras mutation, cetuximab or panitumumab could then be added to irinotecan, or cetuximab could be given alone. (See",
"       <a class=\"local\" href=\"#H8\">",
"        'Cetuximab (Erbitux)'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       If FOLFIRI (with or without bevacizumab) was given as the first-line regimen, cetuximab or panitumumab can be added (if the tumor does not have the K-ras mutation), or the patient can be switched to an oxaliplatin regimen, such as FOLFOX or XELOX.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     A drug targeting VEGF (bevacizumab, aflibercept) may be recommended as a component of second-line treatment even if bevacizumab was given as part of the first-line treatment. However, these drugs should not be used in combination with cetuximab or panitumumab.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      COLORECTAL CANCER CHEMOTHERAPY SIDE EFFECTS",
"     </span>",
"    </p>",
"    <p>",
"     The side effects of colorectal cancer chemotherapy depend upon the type, combination, and schedule of drugs used. The most common side effects of each agent are listed below, but it is important to review the entire range of potential side effects of all of the individual drugs in the chemotherapy regimen with the healthcare team.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      FU and leucovorin",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effects are diarrhea, mucositis (soreness in the mouth), and temporarily lowered blood counts. In general, diarrhea and mucositis are more likely when FU and leucovorin are given five days in a row (rather than weekly), especially in older people. For this reason, most oncologists prefer the weekly, rather than the \"five days in a row\", regimen when using FU and leucovorin. Hair loss is less common with FU plus leucovorin alone than with combinations of irinotecan or oxaliplatin plus",
"     <span class=\"nowrap\">",
"      5-FU/leucovorin.",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Irinotecan",
"     </span>",
"     &nbsp;&mdash;&nbsp;When",
"     given alone, irinotecan usually causes more diarrhea, lower blood counts, more fatigue, and more hair loss compared to 5-FU. When irinotecan is combined with 5-FU and leucovorin (FOLFIRI), the most common side effect is diarrhea. Patients should call their healthcare provider immediately if severe diarrhea develops.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Oxaliplatin",
"     </span>",
"     &nbsp;&mdash;&nbsp;Oxaliplatin can cause numbness and tingling of the hands and feet; this is more likely with longer durations of therapy. This drug can also cause an unusual sensitivity to cold temperatures. This can result in painful spasms of the throat while inhaling cold air or ingesting cold liquids. Patients should not drink cold fluids, avoid inhaling cold air, and avoid exposing the hands and feet to cold when possible in the several days surrounding their oxaliplatin infusions.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Bevacizumab and aflibercept",
"     </span>",
"     &nbsp;&mdash;&nbsp;Bevacizumab and aflibercept both target VEGF and they share many of the same side effects. Because there is a small risk that these agents can impair wound healing, surgery should be avoided for at least four weeks before and after treatment with bevacizumab or aflibercept (if possible) to avoid this potential side effect.",
"    </p>",
"    <p>",
"     Bevacizumab and aflibercept may also cause bleeding in the GI tract or uncommonly, a tear of the bowel during treatment. They can also increase blood pressure or cause protein to spill into the urine. Close monitoring is necessary to detect and treat these problems early.",
"    </p>",
"    <p>",
"     There is an increased risk of blood clots for patients using bevacizumab or aflibercept in combination with 5-FU-containing chemotherapy. Approximately 5 percent of patients have serious events such as strokes and heart attacks during therapy. The risk appears to be highest in patients with prior heart problems and in those over the age of 65. For this reason, use of these drugs may not be recommended for people over age 65 who have had a stroke, transient ischemic attack (TIA), or heart attack within the previous 6 to 12 months.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2233313\">",
"     <span class=\"h2\">",
"      Regorafenib",
"     </span>",
"     &nbsp;&mdash;&nbsp;Like bevacizumab and aflibercept, regorafenib also targets the VEGF pathway and shares many of the same side effects, including bleeding or a tear of the bowel during treatment, and high blood pressure. Unlike bevacizumab and aflibercept, regorafenib is given by itself and not with other chemotherapy agents. Other reported side effects with regorafenib are fatigue, diarrhea, liver damage, and hand-foot syndrome, a condition in which there is soreness, redness, and peeling of the skin of the palms and soles of the feet.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Capecitabine",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effect of capecitabine is hand-foot syndrome. Otherwise, oral 5-FU-like drugs such as capecitabine have the same side effects as intravenous 5-FU, although diarrhea and mucositis are somewhat less common. Side effects of capecitabine may be more common when it is given after a regimen including 5-FU and leucovorin.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Cetuximab",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cetuximab can cause allergic reactions slightly more frequently than bevacizumab. If severe, treatment with cetuximab may need to be stopped. Patients will be closely monitored for allergic reactions during and after their treatment.",
"    </p>",
"    <p>",
"     Other side effects include a skin rash that resembles acne, diarrhea, blood clots in the legs, and low blood levels of magnesium. Low magnesium levels can cause weakness, heart rhythm abnormalities, and lead to low levels of other components of the blood, such as potassium and calcium.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h2\">",
"      Panitumumab",
"     </span>",
"     &nbsp;&mdash;&nbsp;While panitumumab can also cause allergic reactions that, if severe, may require that treatment be stopped, the risk is much lower than with either cetuximab or bevacizumab.",
"    </p>",
"    <p>",
"     Other side effects are similar to those seen with cetuximab including an acne-like skin rash, which may be severe, diarrhea, blood clots in the legs, and low blood levels of magnesium.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      CLINICAL TRIALS",
"     </span>",
"    </p>",
"    <p>",
"     Progress in treating cancer requires that better treatments be identified through clinical trials, which are conducted all over the world. A clinical trial is a carefully controlled way to study the effectiveness of new treatments or new combinations of known therapies. Ask for more information about clinical trials, or read about clinical trials at:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://www.cancer.gov/clinicaltrials/learningabout\">",
"        www.cancer.gov/clinicaltrials/learningabout",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://clinicaltrials.gov/\">",
"        file://clinicaltrials.gov/",
"       </a>",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our Web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10050983\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10050990\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/27/19890?source=see_link\">",
"      Patient information: Colon and rectal cancer (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10051004\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/0/6148?source=see_link\">",
"      Patient information: Colon and rectal cancer (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10051020\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/33/17946?source=see_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/55/41850?source=see_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/36/28234?source=see_link\">",
"      Nonsurgical local treatment strategies for colorectal cancer liver metastases",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/32/44554?source=see_link\">",
"      Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44058?source=see_link\">",
"      Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/29/19930?source=see_link\">",
"      Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=see_link\">",
"      Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/43/36538?source=see_link\">",
"      Toxicity of molecularly targeted antiangiogenic agents: Cardiovascular effects",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/6/9322?source=see_link\">",
"      Acneiform eruption secondary to epidermal growth factor (EGFR) inhibitors",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Society of Clinical Oncology",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cancer.net/portal/site/patient\">",
"      www.cancer.net/portal/site/patient",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Comprehensive Cancer Network",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nccn.com/\">",
"      www.nccn.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Cancer Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;1-800-4-CANCER",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cancer.gov/\">",
"      www.cancer.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Cancer Society",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;1-800-ACS-2345",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cancer.org/\">",
"      www.cancer.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American Gastroenterological Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.gastro.org/\">",
"      www.gastro.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American College of Gastroenterology",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.acg.gi.org/\">",
"      www.acg.gi.org",
"     </a>",
"     )",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h2\">",
"      Patient support",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of online forums where patients can find information and support from other people with similar conditions.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://about.com/\">",
"        About.com",
"       </a>",
"       Cancer Forum",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://cancer.about.com/forum\">",
"      file://cancer.about.com/forum",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/22/40293/abstract/1-6\">",
"      1-6",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 9, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/22/40293?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40293/abstract/1\">",
"      Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40293/abstract/2\">",
"      Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240:644.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40293/abstract/4\">",
"      Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341:2039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40293/abstract/5\">",
"      Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40293/abstract/6\">",
"      Tournigand C, Andr&eacute; T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22:229.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f39_22_40293=[""].join("\n");
var outline_f39_22_40293=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           COLORECTAL CANCER OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           TREATMENT FOR RESECTABLE METASTATIC COLORECTAL CANCER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CHEMOTHERAPY FOR UNRESECTABLE COLORECTAL CANCER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           FIRST-LINE CHEMOTHERAPY FOR METASTATIC COLORECTAL CANCER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           SECOND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           COLORECTAL CANCER CHEMOTHERAPY SIDE EFFECTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           CLINICAL TRIALS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/60/13250\" title=\"figure 1\">",
"           Diagram colon rectum PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f39_22_40294="Basophilic stippling";
var content_f39_22_40294=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F71989&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F71989&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Basophilic stippling of red cells in lead poisoning",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood smear shows basophilic stippling in several red cells from a patient with lead poisoning. The granules represent ribosomal precipitates. A similar picture can be seen in a number of other conditions including thalassemia, megaloblastic anemia, sickle cell anemia, and sideroblastic anemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40294=[""].join("\n");
var outline_f39_22_40294=null;
var title_f39_22_40295="Syndromic immunodeficiencies";
var content_f39_22_40295=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Syndromic immunodeficiencies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40295/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40295/contributors\">",
"     Jeffrey E Ming, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40295/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40295/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40295/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40295/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/22/40295/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of conditions featuring immunodeficiency may also present with clinical problems that are not directly due to the immunologic deficit (",
"    <a class=\"graphic graphic_table graphicRef75043 \" href=\"mobipreview.htm?17/47/18174\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. These conditions, termed syndromic immunodeficiencies, are in contrast to primary immunodeficiencies, in which infection is the primary manifestation and the immune problem is well-characterized. A large variety of manifestations have been described in the different syndromic immunodeficiencies and a number of organ systems may be involved. Some of these conditions feature metabolic derangements or chromosomal anomalies.",
"   </p>",
"   <p>",
"    Several genetic disorders may well be considered as both primary and syndromic immunodeficiencies, since they have both characteristic organ dysfunction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dysmorphology unrelated to the immune system, as well as a consistent, well-defined immune deficiency. Conditions such as Wiskott-Aldrich syndrome and ataxia-telangiectasia could be considered as fitting both categories and are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"     \"Wiskott-Aldrich syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=see_link\">",
"     \"Ataxia-telangiectasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recognition of a syndromic immunodeficiency is important in several respects. For a patient with non-immune related anomalies who presents to the immunologist, it is critical to ascertain if the constellation of malformations is diagnostic for a specific syndrome. This may aid in giving an accurate prognosis for the immune defect. In addition, the diagnosis may alert the clinician to monitor for abnormalities in other organ systems. The prognosis for cognitive or motor development may also be impacted. Alternatively, if a child with one of these syndromes presents initially with non-immune medical problems, then it is important to establish if an immune defect is present so that appropriate intervention can be undertaken. In addition, being able to establish the correct diagnosis may also have implications for the recurrence risk of future pregnancies of the patient or the patient's family and relatives.",
"   </p>",
"   <p>",
"    In this topic review, we will focus on the more common syndromic immune deficiencies in which immune defects are noted. More complete delineation of syndromic immunodeficiencies, including rare conditions and those in which immune defects are only occasionally present, are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Some of these disorders are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35493?source=see_link\">",
"     \"Bloom syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/27/439?source=see_link\">",
"     \"Nijmegen breakage syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CARTILAGE-HAIR HYPOPLASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive form of short-limb dwarfism (metaphyseal chondrodysplasia). Associated features may include fine sparse hair, cellular and humoral immunodeficiencies, Hirschsprung disease, hematologic and skin malignancies, autoimmune disease, and bronchiectasis. CHH is caused by defects in the ribonuclease mitochondrial RNA-processing (RMRP) gene. This disorder is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7992?source=see_link\">",
"     \"Cartilage-hair hypoplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ICF SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ICF syndrome is an autosomal recessive condition comprised of",
"    <strong>",
"     I",
"    </strong>",
"    mmunodeficiency,",
"    <strong>",
"     C",
"    </strong>",
"    entromeric instability, and",
"    <strong>",
"     F",
"    </strong>",
"    acial anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chromosomal methylation is defective in affected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/5\">",
"     5",
"    </a>",
"    ]. Mutations in the gene DNMT3B, which encodes a DNA methyltransferase, are causative in about half of individuals with this syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. However, other patients diagnosed with ICF do not have identified DNMT3B mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Mutations in the ZBTB24 gene, which encodes a transcriptional repressor involved in DNA methylation, were identified in some of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/10\">",
"     10",
"    </a>",
"    ]. There are not any apparent clinical differences between those patients with a DNMT3B mutation and those with a ZBTB24 mutation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Clinical manifestations and laboratory abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mental retardation frequently occurs. Characteristic facial features include ocular hypertelorism, flat nasal bridge, epicanthal folds, and low-set ears.",
"   </p>",
"   <p>",
"    Immunodeficiency is manifest by the development of sinopulmonary, gastrointestinal, and cutaneous infections. The immune defect may affect both immunoglobulin levels and T cell number and function. Generally, at least two immunoglobulin classes are affected in each patient, and agammaglobulinemia can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. T cell number and response to mitogen may be decreased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The centromeric instability most frequently involves chromosomes 1 and 16, often 9, and rarely 2 and 10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/11,14\">",
"     11,14",
"    </a>",
"    ]. Deletions, breaks, interchanges between homologous and nonhomologous chromosomes, and multibranched configurations involving pericentric heterochromatin have been described. The ICF syndrome differs from other chromosome instability syndromes in that no hypersensitivity to clastogenic agents has been demonstrated, so the condition should not be considered a chromosome breakage syndrome.",
"   </p>",
"   <p>",
"    The diagnosis should be considered in individuals with immune deficiency and the characteristic facial appearance. Most patients have mental retardation, although some patients have normal cognitive development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is supportive and is directed to the specific clinical and immunologic problems present in the individual. Allogeneic hematopoietic cell transplantation in patients with severe disease corrects the immunodeficiency and improves growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early diagnosis and intervention can improve outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GRISCELLI SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Griscelli syndrome is an autosomal recessive syndrome that features hypopigmentation and may include immune deficiency",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neurologic deficits, depending upon the specific genetic defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Clinical manifestations and laboratory abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;This condition is characterized by partial albinism, neutropenia and thrombocytopenia, and hemophagocytic lymphohistiocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Neurologic involvement may be progressive, possibly due to cerebral lymphohistiocytic infiltration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Melanosomes accumulate in melanocytes, causing clumps of pigment in hair shafts. The absence of giant granules and the histologic characteristics of the hypopigmentation differentiate this condition from Chediak-Higashi syndrome.",
"   </p>",
"   <p>",
"    The hemophagocytosis may be associated with a viral infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/24\">",
"     24",
"    </a>",
"    ]. Neurologic complications may be caused by lymphohistiocytosis of the central nervous system.",
"   </p>",
"   <p>",
"    Patients are susceptible to fungal, viral, and bacterial infections. The immune abnormalities may affect both the cellular and the humoral immune response, with neutropenia also being noted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Griscelli syndrome should be considered in infants with silvery-gray hair, hepatosplenomegaly, and immune deficiency. Microscopic examination of the hair shaft can be used to confirm the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several mutations have been found in affected patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mutations in MYO5A, which encodes an unconventional myosin, were detected in affected patients with neurologic symptoms, who",
"      <strong>",
"       lacked",
"      </strong>",
"      the hemophagocytic syndrome and also",
"      <strong>",
"       lacked",
"      </strong>",
"      immunologic deficits [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. This is referred to as type 1 Griscelli syndrome (GS1, MIM#214450).",
"     </li>",
"     <li>",
"      Mutations in RAB27A, which encodes a GTP-binding protein of the Ras family, were identified in patients presenting primarily with the hemophagocytic syndrome and abnormal T cell and macrophage activation with variable neurologic involvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/26\">",
"       26",
"      </a>",
"      ]. This is termed type 2 Griscelli syndrome (GS2, MIM#607624) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Type 3 Griscelli syndrome (GS3, MIM#609227) is characterized by partial albinism alone, without immune or neurologic complications, and this type can be due to a mutation in MYO5A or in the gene that encodes for melanophilin (MLPH) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with type 1 or 2 Griscelli syndrome die in childhood, usually secondary to severe neurologic sequelae or recurrent infection. Hematopoietic cell transplantation is the only available curative therapy that has shown some success for patients with type 2 Griscelli syndrome with hemophagocytic lymphohistiocytosis and immunodeficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/23,29-32\">",
"     23,29-32",
"    </a>",
"    ]. Patients with type 3 Griscelli syndrome have a better prognosis, since they lack immune and neurologic complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     p14 DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A syndrome of severe congenital neutropenia, short stature, cutaneous hypopigmentation, coarse facial features, and recurrent respiratory infections with Streptococcus pneumoniae has been described in four members of a single Caucasian family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/33\">",
"     33",
"    </a>",
"    ]. Deficiency of the endosomal adaptor protein p14 (also known as MAPBPIP, encoded by the LAMTOR2 gene) was identified in all patients, and functional reconstitution of granule activity was achieved with p14 gene transfer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/33\">",
"     33",
"    </a>",
"    ]. Defects in cytotoxic T cell activity and abnormal B cell differentiation were also noted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SCHIMKE IMMUNOOSSEOUS DYSPLASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schimke immunoosseous dysplasia is an autosomal recessive condition which features skeletal, renal, and immune abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical manifestations and laboratory abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal features of Schimke immunoosseous dysplasia include short stature (often with prenatal growth deficiency), spondyloepiphyseal dysplasia, defective cellular immunity, and progressive renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific abnormalities include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperpigmented macules are frequently present, especially on the trunk.",
"     </li>",
"     <li>",
"      There is short stature with disproportionate shortening of the trunk and lumbar lordosis. The vertebral bodies may be abnormally shaped and epiphyseal changes are most frequently present in the proximal femur [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Corneal opacities and other ophthalmologic abnormalities may be present.",
"     </li>",
"     <li>",
"      Patients eventually develop proteinuria and nephrotic syndrome, usually due to focal segmental glomerulosclerosis; this frequently progresses to end-stage renal disease.",
"     </li>",
"     <li>",
"      Approximately 50 percent have an arteriopathy with cerebral infarcts",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ischemia. Most patients have normal cognitive development, and those with developmental delay have only a mild delay.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients are prone to viral, fungal, and bacterial infections, with recurrent infections being noted in approximately one-half of patients. T cell deficiency with decreased CD4+ number and impaired T cell function are often present, and humoral defects also occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Lymphopenia is characteristic (94 percent), can be recurrent, and is often associated with other hematological abnormalities including pancytopenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis should be considered in patients with short stature and immune deficiency. Renal function should be assessed if the diagnosis is suspected. Radiographs for the characteristic bony anomalies should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the gene encoding the chromatin remodeling protein SMARCAL1",
"    <span class=\"nowrap\">",
"     (SWI/SNF2-related",
"    </span>",
"    matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1) have been detected in affected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/38\">",
"     38",
"    </a>",
"    ]. The protein participates in DNA-nucleosome restructuring that occurs during gene regulation and DNA replication and recombination. Patients with defects in this gene have reduced thymic function that correlates with clinical phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/39\">",
"     39",
"    </a>",
"    ]. Other genetic loci may also be involved, since almost half of affected patients do not have detectable mutations in the coding region of SMARCAL1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid, renal, and immune function should be monitored on a yearly basis. T cell number, subsets, and function should be assessed. Since humoral defects can also occur, evaluation for these abnormalities should be performed.",
"   </p>",
"   <p>",
"    Renal transplants have been successfully used for those who progress to end-stage renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/63/23543?source=see_link\">",
"     \"General principles of kidney transplantation in children\"",
"    </a>",
"    .) Of note, transplanted kidneys generally do not show recurrence of the renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/41\">",
"     41",
"    </a>",
"    ]. Bone marrow transplant has been used to improve marrow function in severely affected cases, with one child showing markedly improved function at two years post-transplant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DELETION OF CHROMOSOME REGION 22Q11.2 (DIGEORGE SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletion of the 22q11.2 chromosome region is associated with the clinical conditions DiGeorge syndrome, Velocardiofacial syndrome (VCFS), and (less commonly) Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    syndrome. DiGeorge syndrome and VCFS are reviewed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/250?source=see_link\">",
"     \"Syndromes with craniofacial abnormalities\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    syndrome is characterized by ocular hypertelorism, hypospadias, and laryngoesophageal defects. Some patients diagnosed with Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    syndrome have deletions of 22q11, although mutations in a gene on chromosome Xp22, named MID1, have been identified in others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/43\">",
"     43",
"    </a>",
"    ]. It is likely that a relatively small proportion of patients with Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    have deletions of 22q11.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DELETIONS OF CHROMOSOME REGION 10P13-P14",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletions of the chromosome region 10p13-p14 are also associated with DiGeorge syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. The deletions in these patients generally extend beyond the DiGeorge syndrome critical region to include the GATA3 gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/46\">",
"     46",
"    </a>",
"    ]. This gene is also mutated in the syndrome of hypoparathyroidism, deafness, and renal dysplasia (HDR syndrome) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/47\">",
"     47",
"    </a>",
"    ]. Patients with DiGeorge syndrome and 10p13-14 deletions more often have deafness that patients with underlying mutations in 22q11. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PARTIAL DELETIONS OF CHROMOSOME 4P (WOLF-HIRSCHHORN SYNDROME)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deletions of chromosome 4p are associated with mental retardation, growth deficiency, and immune deficiencies. The critical region for the deletion is on chromosome 4p16.3. The deletion occurs de novo in approximately 87 percent of cases (about 80 percent involve the paternal chromosome), and in the remainder of the cases is due to a balanced translocation in one of the parents (most involve the maternal chromosome) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/48-50\">",
"     48-50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Clinical manifestations, laboratory abnormalities, and pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients often have prenatal and postnatal growth failure, mental retardation, microcephaly, widely spaced eyes, and seizures. Hearing loss, optic coloboma, renal anomalies, structural brain anomalies, skeletal anomalies, abnormal tooth development, and congenital heart disease may also be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/51\">",
"     51",
"    </a>",
"    ]. There is some correlation between deletion size and clinical severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients have frequent episodes of respiratory infections, due in part to recurrent aspiration. Antibody deficiencies are also common. Immune defects include common variable immunodeficiency, IgA and IgG2 subclass deficiency, IgA deficiency, and impaired polysaccharide responsiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/53\">",
"     53",
"    </a>",
"    ]. T cell immunity is normal. Immunodeficiency does not appear to correlate with deletion size.",
"   </p>",
"   <p>",
"    The exact pathogenesis of Wolf-Hirschhorn syndrome (WHS) is unknown. Wolf-Hirschhorn syndrome candidate 1 (WHSC1) gene is deleted in all known cases of WHS. This gene encodes an H3K36me3-specific histone methyltransferase (HMTase) that plays a role in transcriptional regulation. One of the factors that WHSC1 modulates is Nkx2-5, a central transcriptional regulator of cardiac development. The interaction of WHSC1 with multiple different transcription factors may account for the variability in clinical phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the deletions are cytogenetically visible on a standard karyotype. In some cases, molecular techniques may be required for the diagnosis if the deletion is relatively small, such as fluorescence in situ hybridization (FISH) or array-based approaches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is supportive and directed to the specific clinical indications. Feeding difficulties are often present and if indicated, gastrostomy tube placement may be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40295/abstract/55\">",
"     55",
"    </a>",
"    ]. Audiologic screen, ophthalmologic evaluation, and careful cardiac exam may be performed. Developmental evaluation and appropriate intervention should be undertaken. Chromosome analysis of the parents should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     BLOOM SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bloom syndrome, an autosomal recessive condition, is associated with short stature, a characteristic facial appearance, and increased risk of neoplasia. Bloom syndrome has been reported in a variety of ethnic groups, with an increased frequency in the Ashkenazi Jewish population. This condition is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35493?source=see_link\">",
"     \"Bloom syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     NIJMEGEN BREAKAGE SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nijmegen breakage syndrome, an autosomal recessive condition, is characterized by short stature and immune defects. The condition has been most frequently described in patients of Eastern European ancestry. This disorder is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/27/439?source=see_link\">",
"     \"Nijmegen breakage syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3253291\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A number of conditions featuring immunodeficiency may also present with clinical problems that are not directly due to the immunologic deficit (",
"      <a class=\"graphic graphic_table graphicRef75043 \" href=\"mobipreview.htm?17/47/18174\">",
"       table 1",
"      </a>",
"      ). These conditions, termed syndromic immunodeficiencies, are in contrast to primary immunodeficiencies, in which infection is the primary manifestation and the immune problem is well-characterized. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome is an autosomal recessive condition caused by defective chromosomal methylation. Mental retardation frequently occurs. Characteristic facial features include ocular hypertelorism, flat nasal bridge, epicanthal folds, and low-set ears. Immunodeficiency is manifest by the development of sinopulmonary, gastrointestinal, and cutaneous infections. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'ICF syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Griscelli syndrome type 2 is an autosomal recessive condition characterized by partial albinism, neutropenia and thrombocytopenia, and hemophagocytic lymphohistiocytosis. Neurologic involvement may be progressive. Patients are susceptible to fungal, viral, and bacterial infections. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Griscelli syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Schimke immunoosseous dysplasia is an autosomal recessive condition with the principal features of short stature (often with prenatal growth deficiency), spondyloepiphyseal dysplasia, defective cellular immunity, and progressive renal failure. Patients are prone to viral, fungal, and bacterial infections. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Schimke immunoosseous dysplasia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Partial deletions of chromosome 4p are associated with mental retardation, growth deficiency, and immune deficiencies. Patients have frequent episodes of respiratory infections, due in part to recurrent aspiration. Antibody deficiencies are common, but T cell immunity is normal. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Partial deletions of chromosome 4p (Wolf-Hirschhorn syndrome)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Syndromic immunodeficiencies that are discussed in other entries include cartilage-hair hypoplasia; p14 deficiency; deletion of the 22q11.2 chromosome region that is associated with the clinical conditions DiGeorge syndrome, Velocardiofacial syndrome (VCFS), and (less commonly) Opitz",
"      <span class=\"nowrap\">",
"       G/BBB",
"      </span>",
"      syndrome; deletions of the chromosome region 10p13-p14 that are also associated with DiGeorge syndrome; Bloom syndrome; and Nijmegen breakage syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7992?source=see_link\">",
"       \"Cartilage-hair hypoplasia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=see_link\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/250?source=see_link&amp;anchor=H15#H15\">",
"       \"Syndromes with craniofacial abnormalities\", section on 'Velocardiofacial (Shprintzen) syndrome'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35493?source=see_link\">",
"       \"Bloom syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/27/439?source=see_link\">",
"       \"Nijmegen breakage syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several genetic disorders may well be considered as both primary and syndromic immunodeficiencies since they have both characteristic organ dysfunction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dysmorphology unrelated to the immune system, as well as a consistent, well-defined immune deficiency. Conditions such as Wiskott-Aldrich syndrome and ataxia-telangiectasia could be considered as fitting both categories and are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"       \"Wiskott-Aldrich syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=see_link\">",
"       \"Ataxia-telangiectasia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/1\">",
"      Ming JE, Stiehm ER, Graham JM Jr. Syndromic immunodeficiencies: genetic syndromes associated with immune abnormalities. Crit Rev Clin Lab Sci 2003; 40:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/2\">",
"      Ming JE, Stiehm ER. Genetic syndromic immunodeficiencies with antibody defects. Immunol Allergy Clin North Am 2008; 28:715.",
"     </a>",
"    </li>",
"    <li>",
"     Ming JE, Graham JM Jr. Genetic disorders, including syndromic immunodeficiencies. In: Immunologic disorders in infants and children, 5th ed, Stiehm ER, Ochs HD, Winkelstein JA (Eds), Elsevier/Saunders, Philadelphia 2004. p.785.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/4\">",
"      Hagleitner MM, Lankester A, Maraschio P, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet 2008; 45:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/5\">",
"      Jeanpierre M, Turleau C, Aurias A, et al. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet 1993; 2:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/6\">",
"      Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/7\">",
"      Xu GL, Bestor TH, Bourc'his D, et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999; 402:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/8\">",
"      Kloeckener-Gruissem B, Betts DR, Zankl A, et al. A new and a reclassified ICF patient without mutations in DNMT3B and its interacting proteins SUMO-1 and UBC9. Am J Med Genet A 2005; 136:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/9\">",
"      Jiang YL, Rigolet M, Bourc'his D, et al. DNMT3B mutations and DNA methylation defect define two types of ICF syndrome. Hum Mutat 2005; 25:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/10\">",
"      de Greef JC, Wang J, Balog J, et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet 2011; 88:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/11\">",
"      Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet 1988; 25:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/12\">",
"      Smeets DF, Moog U, Weemaes CM, et al. ICF syndrome: a new case and review of the literature. Hum Genet 1994; 94:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/13\">",
"      Fasth A, Forestier E, Holmberg E, et al. Fragility of the centromeric region of chromosome 1 associated with combined immunodeficiency in siblings. A recessively inherited entity? Acta Paediatr Scand 1990; 79:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/14\">",
"      Tiepolo L, Maraschio P, Gimelli G, et al. Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency. Hum Genet 1979; 51:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/15\">",
"      Shirohzu H, Kubota T, Kumazawa A, et al. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet 2002; 112:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/16\">",
"      Gennery AR, Slatter MA, Bredius RG, et al. Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency-centromeric instability-facial dysmorphism syndrome. Pediatrics 2007; 120:e1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/17\">",
"      De Ravel TJ, Deckers E, Alliet PL, et al. The ICF syndrome: new case and update. Genet Couns 2001; 12:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/18\">",
"      Griscelli C, Durandy A, Guy-Grand D, et al. A syndrome associating partial albinism and immunodeficiency. Am J Med 1978; 65:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/19\">",
"      Mancini AJ, Chan LS, Paller AS. Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature. J Am Acad Dermatol 1998; 38:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/20\">",
"      Dufourcq-Lagelouse R, Pastural E, Barrat FJ, et al. Genetic basis of hemophagocytic lymphohistiocytosis syndrome (Review). Int J Mol Med 1999; 4:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/21\">",
"      Ca��da�� D, Ozg&uuml;r TT, Asal GT, et al. Griscelli syndrome types 1 and 3: analysis of four new cases and long-term evaluation of previously diagnosed patients. Eur J Pediatr 2012; 171:1527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/22\">",
"      Hurvitz H, Gillis R, Klaus S, et al. A kindred with Griscelli disease: spectrum of neurological involvement. Eur J Pediatr 1993; 152:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/23\">",
"      Klein C, Philippe N, Le Deist F, et al. Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr 1994; 125:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/24\">",
"      Kumar M, Sackey K, Schmalstieg F, et al. Griscelli syndrome: rare neonatal syndrome of recurrent hemophagocytosis. J Pediatr Hematol Oncol 2001; 23:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/25\">",
"      Pastural E, Barrat FJ, Dufourcq-Lagelouse R, et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 1997; 16:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/26\">",
"      M&eacute;nasch&eacute; G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000; 25:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/27\">",
"      Masri A, Bakri FG, Al-Hussaini M, et al. Griscelli syndrome type 2: a rare and lethal disorder. J Child Neurol 2008; 23:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/28\">",
"      M&eacute;nasch&eacute; G, Ho CH, Sanal O, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003; 112:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/29\">",
"      Schuster F, Stachel DK, Schmid I, et al. Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant 2001; 28:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/30\">",
"      Schneider LC, Berman RS, Shea CR, et al. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome). J Clin Immunol 1990; 10:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/31\">",
"      Pachlopnik Schmid J, Moshous D, Boddaert N, et al. Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients. Blood 2009; 114:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/32\">",
"      Al-Ahmari A, Al-Ghonaium A, Al-Mansoori M, et al. Hematopoietic SCT in children with Griscelli syndrome: a single-center experience. Bone Marrow Transplant 2010; 45:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/33\">",
"      Bohn G, Allroth A, Brandes G, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007; 13:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/34\">",
"      Saraiva JM, Dinis A, Resende C, et al. Schimke immuno-osseous dysplasia: case report and review of 25 patients. J Med Genet 1999; 36:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/35\">",
"      Boerkoel CF, O'Neill S, Andr&eacute; JL, et al. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr 2000; 159:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/36\">",
"      Spranger J, Hinkel GK, St&ouml;ss H, et al. Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr 1991; 119:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/37\">",
"      Ludman MD, Cole DE, Crocker JF, Cohen MM Jr. Schimke immuno-osseous dysplasia: case report and review. Am J Med Genet 1993; 47:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/38\">",
"      Boerkoel CF, Takashima H, John J, et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 2002; 30:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/39\">",
"      Lev A, Amariglio N, Levy Y, et al. Molecular assessment of thymic capacities in patients with Schimke immuno-osseous dysplasia. Clin Immunol 2009; 133:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/40\">",
"      Clewing JM, Fryssira H, Goodman D, et al. Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat 2007; 28:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/41\">",
"      Elizondo LI, Huang C, Northrop JL, et al. Schimke immuno-osseous dysplasia: a cell autonomous disorder? Am J Med Genet A 2006; 140:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/42\">",
"      Petty EM, Yanik GA, Hutchinson RJ, et al. Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia. J Pediatr 2000; 137:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/43\">",
"      Quaderi NA, Schweiger S, Gaudenz K, et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 1997; 17:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/44\">",
"      Greenberg F, Elder FF, Haffner P, et al. Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet 1988; 43:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/45\">",
"      Daw SC, Taylor C, Kraman M, et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet 1996; 13:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/46\">",
"      Lichtner P, K&ouml;nig R, Hasegawa T, et al. An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14. J Med Genet 2000; 37:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/47\">",
"      Van Esch H, Groenen P, Nesbit MA, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000; 406:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/48\">",
"      Estabrooks LL, Rao KW, Driscoll DA, et al. Preliminary phenotypic map of chromosome 4p16 based on 4p deletions. Am J Med Genet 1995; 57:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/49\">",
"      Wright TJ, Ricke DO, Denison K, et al. A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Genet 1997; 6:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/50\">",
"      Dallapiccola B, Mandich P, Bellone E, et al. Parental origin of chromosome 4p deletion in Wolf-Hirschhorn syndrome. Am J Med Genet 1993; 47:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/51\">",
"      Battaglia A, Filippi T, Carey JC. Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision. Am J Med Genet C Semin Med Genet 2008; 148C:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/52\">",
"      Zollino M, Murdolo M, Marangi G, et al. On the nosology and pathogenesis of Wolf-Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review. Am J Med Genet C Semin Med Genet 2008; 148C:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/53\">",
"      Hanley-Lopez J, Estabrooks LL, Stiehm R. Antibody deficiency in Wolf-Hirschhorn syndrome. J Pediatr 1998; 133:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/54\">",
"      Nimura K, Ura K, Shiratori H, et al. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009; 460:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40295/abstract/55\">",
"      Battaglia A, Carey JC, Cederholm P, et al. Natural history of Wolf-Hirschhorn syndrome: experience with 15 cases. Pediatrics 1999; 103:830.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3951 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-59E8FFCE15-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40295=[""].join("\n");
var outline_f39_22_40295=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3253291\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CARTILAGE-HAIR HYPOPLASIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ICF SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Clinical manifestations and laboratory abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GRISCELLI SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Clinical manifestations and laboratory abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      p14 DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SCHIMKE IMMUNOOSSEOUS DYSPLASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical manifestations and laboratory abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DELETION OF CHROMOSOME REGION 22Q11.2 (DIGEORGE SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DELETIONS OF CHROMOSOME REGION 10P13-P14",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PARTIAL DELETIONS OF CHROMOSOME 4P (WOLF-HIRSCHHORN SYNDROME)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Clinical manifestations, laboratory abnormalities, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      BLOOM SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      NIJMEGEN BREAKAGE SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3253291\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3951\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3951|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/47/18174\" title=\"table 1\">",
"      Syndromic immunodeficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=related_link\">",
"      Ataxia-telangiectasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35493?source=related_link\">",
"      Bloom syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7992?source=related_link\">",
"      Cartilage-hair hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/63/23543?source=related_link\">",
"      General principles of kidney transplantation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/2/1066?source=related_link\">",
"      Hematopoietic cell transplantation for primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/27/439?source=related_link\">",
"      Nijmegen breakage syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/250?source=related_link\">",
"      Syndromes with craniofacial abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=related_link\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_22_40296="Evaluation of chronic pain in adults";
var content_f39_22_40296=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of chronic pain in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40296/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40296/contributors\">",
"     Howard S Smith, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40296/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40296/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40296/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40296/contributors\">",
"     Kari G Doucette, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/22/40296/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic pain affects more than 100 million people in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/1\">",
"     1",
"    </a>",
"    ] and accounts for 20 percent of outpatient visits, 12 percent of all prescriptions, and over 100 billion dollars in direct and indirect expenses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/2\">",
"     2",
"    </a>",
"    ]. Pain-related expenditures (direct costs and lost wages) in the United States exceed those for cancer, heart disease, and diabetes combined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/3\">",
"     3",
"    </a>",
"    ]. The use and misuse of opioids for management of chronic pain is a major concern, with problems arising from their multiple adverse side effects including drug-dependency, from drug diversion, and from undertreatment of chronic pain symptoms for fear of narcotic abuse. Chronic pain is thus a major medical and social issue, affecting the quality of life of individual patients, their friends and families, the work force, and society in general.",
"   </p>",
"   <p>",
"    A comprehensive pain evaluation is essential to develop an effective plan for treatment. Although there are unique aspects to every individual's pain complaints, there are many common elements to the pain evaluation, irrespective of the pain complaint. An appropriate history and physical examination are vital to proper evaluation. Laboratory studies, imaging, and other diagnostic testing may be appropriate in selected situations.",
"   </p>",
"   <p>",
"    The evaluation of patients complaining of persistent pain is discussed here. The definition, classification, and pathogenesis of chronic pain, and overview of its treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42778?source=see_link\">",
"     \"Overview of the treatment of chronic pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16312?source=see_link\">",
"     \"Definition and pathogenesis of chronic pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544395\">",
"    <span class=\"h1\">",
"     COMMON CAUSES OF CHRONIC PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although pain is one of the most common presenting symptoms to the primary care clinician, only a percentage of patients ultimately develop a chronic pain syndrome. In a study based on a survey of representative population in the United States from 1999 to 2002 (the National Health and Nutrition Examination Survey, NHANES), chronic pain (defined as &gt;three months of pain) was reported as follows: back pain 10.1 percent,",
"    <span class=\"nowrap\">",
"     leg/foot",
"    </span>",
"    pain 7.1 percent,",
"    <span class=\"nowrap\">",
"     arm/hand",
"    </span>",
"    pain 4.1 percent, headache 3.5 percent, chronic regional pain 11.1 percent, widespread pain 3.6 percent; the majority of patients who reported chronic pain reported more than one type of pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic pain can be considered to be in one of four categories. Identifying which of these categories the patient falls into is helpful in designing an appropriate treatment plan, although multifactorial causes of chronic pain are not uncommon. These pain categories can be considered to be [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neuropathic pain (either peripheral, including post-herpetic neuralgia, diabetic neuropathy; or central, including poststroke pain or multiple sclerosis)",
"     </li>",
"     <li>",
"      Musculoskeletal pain (eg, back pain, myofascial pain syndrome, ankle pain)",
"     </li>",
"     <li>",
"      Inflammatory pain (eg, inflammatory arthropathies, infection)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Mechanical/compressive",
"      </span>",
"      pain (eg, renal calculi, visceral pain from expanding tumor masses)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Note that these categories are not entirely mutually exclusive, since back pain might be considered both musculoskeletal or",
"    <span class=\"nowrap\">",
"     mechanical/compressive",
"    </span>",
"    if it results from nerve root compression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544409\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough history is crucial to the evaluation of the patient with chronic pain. Pain assessment should be a routine part of any medical encounter and has been referred to as the &ldquo;fifth vital sign&rdquo; in both hospital and ambulatory settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/6\">",
"     6",
"    </a>",
"    ]. Familiarity with the patient, and input from families, friends, and support systems will aid in assessing the true impact of pain on the patient's life and in determining reasonable goals. It is also helpful to inquire about the patient's perception of why they have persistent pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544416\">",
"    <span class=\"h2\">",
"     Pain characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should review all components of a usual medical history, in addition to specific pain-related items. The patient should be asked a detailed history related to the circumstances surrounding the onset of pain (if known) and potential mechanisms of injury. Open-ended questions, at least initially, should be used to ascertain the nature of the pain. Descriptors (such as sharp, dull, squeezing, throbbing, colicky) can be offered if the patient cannot fully describe their symptoms.",
"   </p>",
"   <p>",
"    Important symptom-related factors to be determined are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pain location",
"     </li>",
"     <li>",
"      Radiation",
"     </li>",
"     <li>",
"      Intensity",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Characteristics/quality",
"      </span>",
"     </li>",
"     <li>",
"      Temporal aspects: duration, onset, changes since onset",
"     </li>",
"     <li>",
"      Constancy or intermittency",
"     </li>",
"     <li>",
"      Characteristics of any breakthrough pain",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Exacerbating/triggering",
"      </span>",
"      factors",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Palliative/relieving",
"      </span>",
"      factors",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544423\">",
"    <span class=\"h2\">",
"     Associated symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other symptoms that may be associated with the patient's pain should be questioned:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Restriction of range of motion, stiffness, or swelling",
"     </li>",
"     <li>",
"      Muscle aches, cramps, or spasms",
"     </li>",
"     <li>",
"      Color or temperature changes",
"     </li>",
"     <li>",
"      Changes in sweating",
"     </li>",
"     <li>",
"      Changes in skin, hair, or nail growth",
"     </li>",
"     <li>",
"      Changes in muscle strength",
"     </li>",
"     <li>",
"      Changes in sensation, either positive",
"      <span class=\"nowrap\">",
"       (dysesthesias/itching)",
"      </span>",
"      or negative (numbness)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544430\">",
"    <span class=\"h2\">",
"     Pain impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should be questioned about the impact of pain on function (social and physical) and overall quality of life. Specific questions to ask include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Social and recreational functioning:",
"      </strong>",
"      How often do you participate in pleasurable activities, such as hobbies, going out to movies or concerts, socializing with friends, and travel? Over the past week, how often has pain interfered with these activities?",
"     </li>",
"     <li>",
"      <strong>",
"       Mood, affect, and anxiety",
"      </strong>",
"      : Has pain interfered with your energy, mood, personality? Are you readily tearful?",
"     </li>",
"     <li>",
"      <strong>",
"       Relationships",
"      </strong>",
"      : Has pain affected relationships with family",
"      <span class=\"nowrap\">",
"       members/significant",
"      </span>",
"      <span class=\"nowrap\">",
"       others/friends/colleagues?",
"      </span>",
"     </li>",
"     <li>",
"      <strong>",
"       Occupation",
"      </strong>",
"      : Has the pain required that you modify your work responsibilities",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hours? When was the last time you worked, and (if applicable) why have you stopped working?",
"     </li>",
"     <li>",
"      <strong>",
"       Sleep",
"      </strong>",
"      : Does pain interfere with your sleep? How often over the past week?",
"     </li>",
"     <li>",
"      <strong>",
"       Exercise",
"      </strong>",
"      : How often do you do some sort of exercise? Over the past week, how often has pain interfered with your ability to exercise?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544437\">",
"    <span class=\"h3\">",
"     Activities of daily living",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of pain on basic activities of daily living (ADLs) should be assessed, addressing the patient's ability to bathe, dress, go to the toilet, and feed without help. Questions also should be asked about activities required to live independently (instrumental activities of daily living or IADLs), including the ability to shop, use transportation, prepare meals, do housework, manage finances and medications.",
"   </p>",
"   <p>",
"    Specific questions which, in conjunction with a physical examination, may help to document a patient's function include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is the patient able to perform activities of daily living?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Can they brush their teeth, comb their hair, bathe?",
"     </li>",
"     <li>",
"      Can they manage using the toilet and cleaning without assistance?",
"     </li>",
"     <li>",
"      Can they feed themselves?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is the patient ambulatory?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Do they need an assist-device (eg, cane, brace, walker, crutch)?",
"     </li>",
"     <li>",
"      Has their ambulation changed since the pain started?",
"     </li>",
"     <li>",
"      How far can the patient ambulate?",
"     </li>",
"     <li>",
"      How fast can they walk? (eg, how long does it take the patient to get from the parking lot to your office, compared to your own time?)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is the patient able to dress independently?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Able to put",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      own shoes and socks on?",
"     </li>",
"     <li>",
"      Can the patient put a shirt on himself?",
"     </li>",
"     <li>",
"      If the patient wears a bra, is she able to put it on by herself?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is the patient able to manage household chores, including shopping, cooking, bill paying?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Is the patient able to drive a car?",
"     </li>",
"     <li>",
"      Can the patient get in and out of a car with relative ease?",
"     </li>",
"     <li>",
"      Is the patient able to get up and down from sitting on a chair or toilet?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544444\">",
"    <span class=\"h2\">",
"     Pain intensity scales",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain intensity can only be determined by the patient's report. Measures of pain intensity are not meant to compare one person's pain with another's. Pain scales are reliable only to compare the intensity of one patient's pain at different times, thus allowing clinicians and patients to judge whether pain intensity is increasing or decreasing with time and treatment.",
"   </p>",
"   <p>",
"    A number of different measurements for pain intensity have been developed, and no scale is clearly better than another. Most scales in common use are unidimensional. Some patients have greater ease with a verbal scale, others with a numerical rating scale (NRS) or a visual analog scale (VAS) (",
"    <a class=\"graphic graphic_figure graphicRef62346 \" href=\"mobipreview.htm?41/46/42723\">",
"     figure 1",
"    </a>",
"    ). The NRS-11 (a number scale from 0 to 10) is perhaps the most commonly used pain intensity rating tool. A verbal scale offers descriptors, such as \"no pain, mild pain, moderate pain, severe pain, unbearable pain\" that can be graded on each visit. Pain maps (body maps) can be useful for patients who have difficulty with verbal expression. A front and rear view of the body is presented on paper, and the patient is asked to pencil in the location of the pain. Asking the patient to map out the distribution of pain on their own body also may be helpful.",
"   </p>",
"   <p>",
"    A consistent measure of pain for an individual patient should be used across time. Patients should be asked to rate both pain present at the time of visit, and pain experienced over the past week.",
"   </p>",
"   <p>",
"    Multidimensional instruments provide more information than unidimensional scales, but take longer to administer. Since chronic pain affects a person&rsquo;s whole life, many experts feel that it is essential to use multidimensional instruments for appropriate assessment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Brief Pain Inventory (BPI) is a short, &ldquo;user-friendly&rdquo; self-administered, practical questionnaire that is in many languages and has been validated for cancer pain and noncancer pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. The BPI assesses pain location, intensity, and pattern as well as patient beliefs and the impact of pain on the patient&rsquo;s quality of life.",
"     </li>",
"     <li>",
"      The revised version of the short form of the McGill Pain Questionnaire (SF-MPQ-2) includes a selection of descriptive words to characterize qualities of pain, a pain intensity scale, a questionnaire on the use of analgesic medications and prior pain experience, and a human figure drawing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/9\">",
"       9",
"      </a>",
"      ]. Specific words selected to characterize the pain quality may suggest a particular pathophysiology (eg, burning, dysesthetic, or electric-shock-like pain may imply neuropathic pain).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific instruments have been developed for the evaluation of neuropathic pain, and include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Neuropathic Pain Scale, administered verbally, with established predictive validity that assesses different qualities of neuropathic pain and can be used to follow treatment response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/10-12\">",
"       10-12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The S-LANSS score (8-Bennett 05) - A self-support version of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), consisting of five self-reported items and two patient-assessed sensory testing items (",
"      <a class=\"graphic graphic_table graphicRef62906 \" href=\"mobipreview.htm?11/60/12237\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The DN4 - A clinician-administered tool with 10 items based on history and physical examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/14\">",
"       14",
"      </a>",
"      ], has a cut-off value of",
"      <span class=\"nowrap\">",
"       4/10",
"      </span>",
"      for the diagnosis of neuropathic pain (positive item score = 1, negative items score = 0). The DN4 has a positive predictive value of 86 percent, sensitivity of 82.9 percent, and a specificity of 89.9 percent (",
"      <a class=\"graphic graphic_figure graphicRef74662 \" href=\"mobipreview.htm?42/19/43326\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544451\">",
"    <span class=\"h2\">",
"     Previous evaluation and/or treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior evaluation and treatment for pain should be explored. Attempts should be made, with patient permission, to obtain all records from clinician offices, hospitals, imaging",
"    <span class=\"nowrap\">",
"     centers/laboratories,",
"    </span>",
"    and pharmacies.",
"   </p>",
"   <p>",
"    Questions to be asked include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Have you experienced other painful illnesses?",
"     </li>",
"     <li>",
"      What health care professionals have treated you in the past, or are currently treating you? (with clinician addresses and phone numbers).",
"     </li>",
"     <li>",
"      What",
"      <span class=\"nowrap\">",
"       tests/imaging",
"      </span>",
"      studies or other diagnostic studies have you had?",
"     </li>",
"     <li>",
"      What medications have been tried? How have you responded to",
"      <span class=\"nowrap\">",
"       medications/treatments",
"      </span>",
"      in the past? This information should include dosing, length of medication trials, frequency of use of \"prn\" medications, perceived effectiveness, and perceived adverse or other side effects.",
"     </li>",
"     <li>",
"      Have you seen a complementary or alternative medical practitioner for your symptoms? If so, was their treatment helpful?",
"     </li>",
"     <li>",
"      Do you use herbal medications, vitamins or other supplements? Do you follow a special diet?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544458\">",
"    <span class=\"h2\">",
"     Patient perceptions and psychological factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's personal and family history should be explored as part of a behavioral assessment. It is important to inquire about a patient's support system.",
"   </p>",
"   <p>",
"    Patients should be asked about possible maladaptive behavioral patterns that may influence the course of pain rehabilitation. Of particular concern is history related to underlying psychological disorders (eg, depression, anxiety) or a history of substance abuse, including prescription drugs.",
"   </p>",
"   <p>",
"    A patient's specific beliefs about their pain and their prior healthcare experiences should be understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/15\">",
"     15",
"    </a>",
"    ]. It is crucial to determine the patient's expectations for treatment and to educate and counsel patients with respect to how realistic these expectations and goals are. A significant mismatch or gap between expectations and reality will lead inevitably to frustration for both patient and clinician.",
"   </p>",
"   <p>",
"    Questions to be asked include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      What is the patient's perception of why they have persistent pain?",
"     </li>",
"     <li>",
"      Does the patient believe an adequate diagnostic work-up has been done?",
"     </li>",
"     <li>",
"      Does the patient have expectations for specific types of treatments?",
"     </li>",
"     <li>",
"      What are the patient's expectations or goals of treatment (eg, extent of pain relief and functional improvement)?",
"     </li>",
"     <li>",
"      How involved does the patient expect to be in their treatment?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544465\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete physical examination, including a detailed neurologic assessment, should be performed, regardless of the patient's area of complaint. A baseline evaluation will allow ongoing assessment of a patient's progress in terms of functional capacity, range of motion, endurance, strength, and other pain-related clinical manifestations.",
"   </p>",
"   <p>",
"    Relevant components of the physical examination for specific types of chronic pain are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/36/19018?source=see_link\">",
"     \"Diagnostic approach to abdominal pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31864?source=see_link\">",
"     \"Evaluation of chronic pelvic pain in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/15/34042?source=see_link\">",
"     \"Diagnostic approach to chest pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/55/8056?source=see_link\">",
"     \"Clinical manifestations and diagnosis of fibromyalgia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/15/34039?source=see_link\">",
"     \"Evaluation of the adult with polyarticular pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Important information can be obtained by observing the patient as they walk into the examination room, and by observing pain behaviors throughout the examination. The patient's general appearance, dress, and hygiene should be noted.",
"   </p>",
"   <p>",
"    Compensatory movements, or splinting, may serve to protect a painful region of the body, and consistency of such activities should be observed. Suggestions of pain embellishment should be noted, but do not necessarily indicate malingering since patients with longstanding chronic pain may enhance their presenting symptoms to assure themselves that the clinician will accept and explore their complaints.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544479\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain is a subjective complaint and cannot be assessed with laboratory studies. However, appropriate laboratory, imaging, and other testing can be helpful to evaluate or follow certain painful conditions. It should be borne in mind, however, that finding an abnormality in a diagnostic test does not confirm that this is the source of the patient&rsquo;s pain syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544486\">",
"    <span class=\"h2\">",
"     Blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;&ldquo;Routine&rdquo; blood studies are not indicated, but directed testing should be ordered when specific causes of pain (ie, rheumatologic, infectious, or oncologic) are suggested by the patient's history or physical examination. Serologic markers of inflammation such as erythrocyte sedimentation rate and C-reactive protein should be normal in degenerative or neuropathic causes of pain but may be elevated in patients with polymyalgia rheumatica, rheumatoid arthritis, or infectious processes (eg, septic discitis). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13832?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polymyalgia rheumatica\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544493\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is likely that patients with chronic pain complaints will already have had diagnostic imaging studies from previous evaluations, and these should be obtained and reviewed if possible, to avoid unnecessary radiation exposure and expense.",
"   </p>",
"   <p>",
"    Indications for imaging and other studies will vary depending on the location of the patient's pain and are discussed in multiple other topics in UpToDate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31864?source=see_link\">",
"     \"Evaluation of chronic pelvic pain in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/15/34042?source=see_link\">",
"     \"Diagnostic approach to chest pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/7/9335?source=see_link\">",
"     \"Clinical evaluation of musculoskeletal chest pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12633?source=see_link\">",
"     \"Diagnostic testing for low back pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/24/1418?source=see_link\">",
"     \"Evaluation of the patient with neck pain and cervical spine disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21146?source=see_link\">",
"     \"Overview of cancer pain syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11431?source=see_link\">",
"     \"Overview of craniofacial pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/15/34039?source=see_link\">",
"     \"Evaluation of the adult with polyarticular pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544500\">",
"    <span class=\"h2\">",
"     Other testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurophysiologic testing, principally nerve conduction studies (NCV) and electromyography (EMG), are frequently employed in suspected disorders of the peripheral nervous system. The usual techniques, with surface electrodes for nerve stimulation, measure activity of the largest and fastest conducting sensory and motor myelinated nerve fibers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/46/1769?source=see_link\">",
"     \"Overview of electromyography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unfortunately, NCV and EMG studies may be normal in patients with polyneuropathies or focal nerve lesions with only small-fiber involvement. Additionally, pain specialists may perform interventional testing of nerves or joints via a double-comparative local anesthetic blockade (eg, with one block using a longer acting anesthetic). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544507\">",
"    <span class=\"h1\">",
"     REFERRAL TO A PAIN SPECIALIST",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Institute of Medicine in the United States, recognizing the enormous population burden of chronic pain, formed a committee to explore related issues and published a report in 2011 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/16\">",
"     16",
"    </a>",
"    ]. This report identified limitations in the training of generalist physicians in the management of chronic pain, noting that it is not realistic or desirable that pain management be delegated exclusively to pain specialists. To support generalist clinicians in the management of their patients with chronic pain, issues related to training, education, and reimbursement need to be addressed. &nbsp;",
"   </p>",
"   <p>",
"    While many patients with chronic pain can be managed without specialty referral, patients may require referral to a pain specialist for one of several reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Symptoms that are debilitating",
"     </li>",
"     <li>",
"      Symptoms located at multiple sites",
"     </li>",
"     <li>",
"      Symptoms that do not respond to initial therapies",
"     </li>",
"     <li>",
"      Escalating need for pain medication",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When to refer to a pain specialist remains a controversial question; referral should certainly occur by the time significant disability or loss of functioning are observed or when pain behaviors have coalesced or maladaptive coping strategies have begun to emerge. Most pain specialists feel that referrals are frequently made too late in the course of pain, when patients are beyond \"the golden hour.\" This is especially true of neuropathic forms of pain and cancer pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544514\">",
"    <span class=\"h1\">",
"     SPECIAL CONSIDERATIONS IN SPECIFIC POPULATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Psychiatric comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;A significant portion of patients presenting with chronic pain also have histories of primary psychiatric comorbidity. The inclusion of Axis I",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    II diagnoses in the patient's history should never provide the grounds to dismiss the patient's complaints of pain.",
"   </p>",
"   <p>",
"    Nociceptive pathways are modulated by psychological processes, which probably play an important role in amplifying pain symptomatology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/17\">",
"     17",
"    </a>",
"    ]. Depression, anxiety, posttraumatic stress disorder, substance abuse, and other psychiatric disorders can present formidable obstacles to diagnosing and treating many pain syndromes. In one prospective study, patients with a mental health diagnosis were twice as likely to be prescribed an opioid medication three years later than those without a psychiatric diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with longstanding or complex pain problems should be treated with a multidisciplinary approach that includes an evaluation and close collaboration by a mental health professional who can diagnose and treat the psychologic aspects of the dysfunction.",
"   </p>",
"   <p>",
"    It is important to distinguish patients with underlying psychiatric illness from those whose psychological symptoms (anxiety, depression, or other expressions of psychopathology) arise secondary to their pain. Chronic pain can take an emotional toll, affecting relationships with loved ones, friends, and potentially employers. Besides living with pain, the patient may feel angry, isolated, helpless, and fearful that he or she has lost the ability to engage in productive employment, or be a good spouse, parent, or friend. Somatoform pain disorder, in which pain is not fully explained by a general medical condition, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5450?source=see_link&amp;anchor=H18#H18\">",
"     \"Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis\", section on 'Somatoform disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depression and anxiety, two of the most common psychological correlates of chronic pain, complicate the patient's conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/19\">",
"     19",
"    </a>",
"    ]. Sleep disturbance, loss of appetite, lack of energy, and diminished physical activity contribute to an increasingly debilitated state and amplify the patient's pain symptoms. Patients commonly describe a lack of pleasure and an absence of control in their lives.",
"   </p>",
"   <p>",
"    A number of instruments or psychological tests are widely employed to screen the psychological profiles of chronic pain patients. Two that are in common use are the Beck Depression Inventory and the Minnesota Multiphasic Personality Inventory II (MMPI-2). The former is a brief, 21-item, self-reporting questionnaire that assesses the degree to which depressive symptomatology is present. The latter is an extensive",
"    <span class=\"nowrap\">",
"     true/false",
"    </span>",
"    questionnaire consisting of more than 500 items factored across 10 clinical scales, as well as a variety of validity, secondary, and experimental scales. The MMPI-2 has been used extensively to verify clinical impressions about the psychological aspects of a patient's chronic pain and to predict responses to medical and surgical pain treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544523\">",
"    <span class=\"h2\">",
"     Older adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful pain management in the older adult, as with younger individuals, is predicated on a comprehensive pain assessment. Specific goals include determining the type and cause of pain; identifying exacerbating co-morbidities; reviewing beliefs, attitudes, and expectations regarding pain; and gathering information that would assist and impact an individualized treatment plan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Self-report of pain is the most reliable source for the cognitively intact and communicative older adult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/24\">",
"     24",
"    </a>",
"    ]. However, older patients may have more difficulty in communicating their pain, and are often undertreated for pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/25\">",
"     25",
"    </a>",
"    ]. Deficits in vision, hearing and cognition are common in this population and need to be identified prior to beginning the interview. Adjustments to accommodate for deficits that may compromise the assessment need to be considered, especially when selecting appropriate pain assessment instruments. It also may be beneficial to query other family members or caregivers for corroboration and additional perspective on medical history, predominant mood and affect, and physical and social functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For a variety of reasons, older adults may be more hesitant than younger individuals to report pain. Some &ldquo;barriers&rdquo; to discussing pain include perception that pain simply is a concomitant of aging; reluctance to &rdquo;bother&rdquo; their physician with complaints of pain; not wanting to detract the physician&rsquo;s attention away from other &ldquo;medical&rdquo; complaints. Older adults also may use different descriptive terms for their pain (aching, soreness, hurting, discomfort), including some that are not included in commonly used pain instruments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/18,25\">",
"     18,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544530\">",
"    <span class=\"h3\">",
"     Medication history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful medication history must include all current and past medications, dosages, side effects, and response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/26\">",
"     26",
"    </a>",
"    ]. Many older individuals living in the community cannot accurately provide this information. It is helpful to ask that they bring in all current medications, as well as to obtain corroborative information from other treating physicians and from relatives and to obtain the name and phone number of the patient's current pharmacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=see_link\">",
"     \"Drug prescribing for older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should be specifically questioned about use of herbal and dietary supplements, as well as over the counter medications, in addition to prescription medications. Data from 2002 indicate that approximately one quarter of older women in the US regularly use an herbal or dietary supplement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/17\">",
"     17",
"    </a>",
"    ]. Additionally, patients should be asked about alcohol use, with specific inquiry regarding type, frequency and amount. Tobacco products and illicit drug use are important elements of inquiry as well.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544537\">",
"    <span class=\"h3\">",
"     Functional assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognition is grossly assessed during the process of the health interview. More detailed assessment may be indicated for patients who seem to have cognitive impairment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=see_link\">",
"     \"Evaluation of cognitive impairment and dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544544\">",
"    <span class=\"h3\">",
"     Psychosocial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mood, social support systems, recreational involvement, and financial resources are important to the psychosocial assessment. These factors influence how the patient experiences the pain and how the patients may respond to various treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544551\">",
"    <span class=\"h3\">",
"     Beliefs and attitudes about pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The context in which older adults perceive pain is relevant to the overall assessment. Older adults are more likely to view severe discomfort as a sign of serious or life-threatening illness (eg, recurrence of cancer). Pain can signify loss of independence, debilitating illness, or may be regarded as a natural consequence of the aging process and therefore be underreported.",
"   </p>",
"   <p>",
"    Identifying coping skills among the elderly is important so that the clinician can encourage the use of previously successful skills or modify treatment interventions to promote effective coping skills. The most consistent findings in studies is that older persons use prayer and hope as pain coping mechanisms to a greater extent than do younger patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544558\">",
"    <span class=\"h3\">",
"     Long-term care facilities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have identified problems with pain assessment in the nursing home setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/19,29,30\">",
"     19,29,30",
"    </a>",
"    ]. In one study involving focus groups in 12 nursing homes, behavioral changes and observable physical changes were used as cues for the possible presence of pain, rather than formal assessment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/19\">",
"     19",
"    </a>",
"    ]. Pain assessment was recognized as more problematic for residents whose relationships with nursing staff were more limited and who were considered behaviorally \"difficult.\"",
"   </p>",
"   <p>",
"    Two resources to facilitate implementing an institutional plan for pain assessment are the American Geriatric Society Panel on Persistent Pain in Older Adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/24\">",
"     24",
"    </a>",
"    ] and the American Medical Directors Association Chronic Pain Management in the Long Term Care Setting guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544565\">",
"    <span class=\"h2\">",
"     Nonverbal or cognitively impaired adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five key principles to guide pain assessment in nonverbal populations have been identified by the American Society for Pain Management Nursing (ASPMN) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/31\">",
"     31",
"    </a>",
"    ]. These are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obtain a self-report of pain, if at all possible",
"     </li>",
"     <li>",
"      investigate for possible pathologies that could produce pain",
"     </li>",
"     <li>",
"      Observe for behaviors that may indicate pain",
"     </li>",
"     <li>",
"      Solicit a surrogate report from an observer or caregiver",
"     </li>",
"     <li>",
"      Consider the use of an analgesic trial to evaluate whether pain management results in a reduction in the behavioral indicators thought to be related to pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A variety of behavioral tools have been developed for pain assessment in nonverbal older adults, but none has been found to have sufficient reliability and validity to support broad adoption in clinical practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/31-37\">",
"     31-37",
"    </a>",
"    ]. These tools include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Checklist of Nonverbal Pain Indicators (CNPI) for acute care [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/25,38\">",
"       25,38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Doloplus 2 for nonverbal older adults who speak French, Dutch and Norwegian [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Pain Assessment Checklist for Seniors with Severe Dementia (PACSLAC) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/40\">",
"       40",
"      </a>",
"      ], addresses all six pain behavioral categories included in the AGS Guidelines [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/41\">",
"       41",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      The Pain Assessment in Advanced Dementia (PAINAD) Scale",
"      <strong>",
"      </strong>",
"      for nonverbal older adults with advanced dementia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Behavioral Pain Scale (BPS) for critically ill sedated adult patients undergoing mechanical ventilation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Critical Care Pain Observation Tool (CPOT) also for critically ill patients unable to communicate verbally [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40296/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/12/23746?source=see_link\">",
"       \"Patient information: Chronic pain (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15544692\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic pain, accounting for 20 percent of outpatient visits, can be considered in one of four categories: neuropathic, musculoskeletal, inflammatory, and",
"      <span class=\"nowrap\">",
"       mechanical/compressive.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H15544395\">",
"       'Common causes of chronic pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A thorough history for pain evaluation should include inquiry into pain characteristics, impact of pain on the quality of life, and usual activities. Pain intensity scales cannot compare pain severity between patients but can evaluate changes over time in one patient's pain syndrome. Important components of the history are the patient's previous medical experience for pain and their expectations for pain relief. (See",
"      <a class=\"local\" href=\"#H15544409\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical examination should include a complete examination, regardless of the area of pain. Relevant findings include the clinician's observation of the patient's ability to move and general appearance. (See",
"      <a class=\"local\" href=\"#H15544465\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pain is a subjective complaint and cannot be assessed with laboratory studies. Diagnostic testing will depend on the patient's particular pain and prior evaluation. Interventional testing such as nerve conduction studies and electromyography may not detect focal nerve lesions involving only small nerve fibers. Multiple questionnaires have been developed to assess neuropathic pain and follow treatment response. (See",
"      <a class=\"local\" href=\"#H15544507\">",
"       'Referral to a pain specialist'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15544479\">",
"       'Diagnostic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Optimal timing for a referral to a pain specialty clinic is uncertain, but earlier referral for patients whose pain is debilitating or who are exhibiting maladaptive coping strategies is preferable. (See",
"      <a class=\"local\" href=\"#H15544507\">",
"       'Referral to a pain specialist'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pain evaluation in older patients is particularly challenging. Assessment may require involving caregivers in the history and use of instruments for nonverbal patients. A complete assessment includes a medication history, functional, and psychosocial assessment and exploration of individual beliefs and coping strategies. (See",
"      <a class=\"local\" href=\"#H15544523\">",
"       'Older adults'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Available at file://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx (Accessed on January 02, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/2\">",
"      Alford DP, Krebs EE, Chen IA, et al. Update in pain medicine. J Gen Intern Med 2010; 25:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/3\">",
"      Pizzo PA, Clark NM. Alleviating suffering 101--pain relief in the United States. N Engl J Med 2012; 366:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/4\">",
"      Hardt J, Jacobsen C, Goldberg J, et al. Prevalence of chronic pain in a representative sample in the United States. Pain Med 2008; 9:803.",
"     </a>",
"    </li>",
"    <li>",
"     Institute for Clinical Systems Improvement. Health care guideline: Assessment and management of chronic pain. Fourth edition November 2009. file://www.icsi.org/pain__chronic__assessment_and_management_of_14399/pain__chronic__assessment_and_management_of__guideline_.html (Accessed on December 09, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/6\">",
"      Lorenz KA, Sherbourne CD, Shugarman LR, et al. How reliable is pain as the fifth vital sign? J Am Board Fam Med 2009; 22:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/7\">",
"      Keller S, Bann CM, Dodd SL, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004; 20:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/8\">",
"      Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/9\">",
"      Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 2009; 144:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/10\">",
"      Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997; 48:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/11\">",
"      Lynch ME, Clark AJ, Sawynok J. Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. Pain 2003; 103:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/12\">",
"      Jensen MP, Dworkin RH, Gammaitoni AR, et al. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 2005; 6:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/13\">",
"      Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/14\">",
"      Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/15\">",
"      Okifuji A, Ackerlind S. Behavioral medicine approaches to pain. Med Clin North Am 2007; 91:45.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/17\">",
"      Nahin RL, Fitzpatrick AL, Williamson JD, et al. Use of herbal medicine and other dietary supplements in community-dwelling older people: Baseline data from the ginkgo evaluation of memory study. J Am Geriatr Soc 2006; 54:1725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/18\">",
"      Closs SJ, Briggs M. Patients' verbal descriptions of pain and discomfort following orthopaedic surgery. Int J Nurs Stud 2002; 39:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/19\">",
"      Clark L, Jones K, Pennington K. Pain assessment practices with nursing home residents. West J Nurs Res 2004; 26:733.",
"     </a>",
"    </li>",
"    <li>",
"     Hathaway SR, McKinly JC. The Minnesota multiphasic personality inventory manual, Psychological Corporation, New York 1967.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/21\">",
"      Long CJ. The relationship between surgical outcome and MMPI profiles in chronic pain patients. J Clin Psychol 1981; 37:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/22\">",
"      BECK AT, WARD CH, MENDELSON M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/23\">",
"      Hadjistavropoulos T, Herr K, Turk DC, et al. An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain 2007; 23:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/24\">",
"      AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002; 50:S205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/25\">",
"      Feldt KS, Ryden MB, Miles S. Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture. J Am Geriatr Soc 1998; 46:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/26\">",
"      Bruckenthal P. Assessment of pain in the elderly adult. Clin Geriatr Med 2008; 24:213.",
"     </a>",
"    </li>",
"    <li>",
"     Corran, TM, GIbson, SJ, Farrell, MJ, et al. Comparison of chronic pain experience between younger and elderly patients. In: Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, 2, Gebhart, GF, Hammond, DL, Jenson, TS (Eds), IASP Press, Seattle 1994. p.895.",
"    </li>",
"    <li>",
"     McCraken, LM. Age, pain, and impairment: Results from two clinical samples. In: Abstracts: 7th World Congress on Pain, IASP Press, Seattle 1993. p.99.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/29\">",
"      Kaasalainen S, Coker E, Dolovich L, et al. Pain management decision making among long-term care physicians and nurses. West J Nurs Res 2007; 29:561.",
"     </a>",
"    </li>",
"    <li>",
"     AMDA. Clinical practice guideline: Pain management (revised 2009). www.amda.com/tools/cpg/chronicpain.cfm.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/31\">",
"      Herr K, Coyne PJ, Key T, et al. Pain assessment in the nonverbal patient: position statement with clinical practice recommendations. Pain Manag Nurs 2006; 7:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/32\">",
"      Bjoro K, Herr K. Assessment of pain in the nonverbal or cognitively impaired older adult. Clin Geriatr Med 2008; 24:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/33\">",
"      Herr K, Bjoro K, Decker S. Tools for assessment of pain in nonverbal older adults with dementia: a state-of-the-science review. J Pain Symptom Manage 2006; 31:170.",
"     </a>",
"    </li>",
"    <li>",
"     Hadjistavropoulos T. Assessing pain in older persons with severe limitations in ability to communicate. In: Pain in Older Persons, Gibson SJ, Weiner DK (Eds), IASP Press, Seattle 2005. p.135.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/35\">",
"      Stolee P, Hillier LM, Esbaugh J, et al. Instruments for the assessment of pain in older persons with cognitive impairment. J Am Geriatr Soc 2005; 53:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/36\">",
"      Zwakhalen SM, Hamers JP, Abu-Saad HH, Berger MP. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatr 2006; 6:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/37\">",
"      van Herk R, van Dijk M, Baar FP, et al. Observation scales for pain assessment in older adults with cognitive impairments or communication difficulties. Nurs Res 2007; 56:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/38\">",
"      Feldt KS. The checklist of nonverbal pain indicators (CNPI). Pain Manag Nurs 2000; 1:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/39\">",
"      Lefebvre-Chapiro S. The Doloplus 2 scale - evaluating pain in the elderly. Eur J Palliat Care 2001; 8:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/40\">",
"      Fuchs-Lacelle S, Hadjistavropoulos T. Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC). Pain Manag Nurs 2004; 5:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/41\">",
"      American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009; 57:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/42\">",
"      Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003; 4:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/43\">",
"      Payen JF, Bru O, Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001; 29:2258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40296/abstract/44\">",
"      G&eacute;linas C, Fillion L, Puntillo KA, et al. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 2006; 15:420.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2760 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-DE6246C94F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40296=[""].join("\n");
var outline_f39_22_40296=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15544692\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544395\">",
"      COMMON CAUSES OF CHRONIC PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544409\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544416\">",
"      Pain characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544423\">",
"      Associated symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544430\">",
"      Pain impact",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15544437\">",
"      - Activities of daily living",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544444\">",
"      Pain intensity scales",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544451\">",
"      Previous evaluation and/or treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544458\">",
"      Patient perceptions and psychological factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544465\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544479\">",
"      DIAGNOSTIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544486\">",
"      Blood tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544493\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544500\">",
"      Other testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544507\">",
"      REFERRAL TO A PAIN SPECIALIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544514\">",
"      SPECIAL CONSIDERATIONS IN SPECIFIC POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Psychiatric comorbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544523\">",
"      Older adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15544530\">",
"      - Medication history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15544537\">",
"      - Functional assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15544544\">",
"      - Psychosocial assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15544551\">",
"      - Beliefs and attitudes about pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15544558\">",
"      - Long-term care facilities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15544565\">",
"      Nonverbal or cognitively impaired adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15544692\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2760\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2760|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/46/42723\" title=\"figure 1\">",
"      Visual analog scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/19/43326\" title=\"figure 2\">",
"      DN4 questionnaire",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2760|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/60/12237\" title=\"table 1\">",
"      S-LANSS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/7/9335?source=related_link\">",
"      Clinical evaluation of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/55/8056?source=related_link\">",
"      Clinical manifestations and diagnosis of fibromyalgia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13832?source=related_link\">",
"      Clinical manifestations and diagnosis of polymyalgia rheumatica",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16312?source=related_link\">",
"      Definition and pathogenesis of chronic pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/36/19018?source=related_link\">",
"      Diagnostic approach to abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/15/34042?source=related_link\">",
"      Diagnostic approach to chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/21/12633?source=related_link\">",
"      Diagnostic testing for low back pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=related_link\">",
"      Drug prescribing for older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31864?source=related_link\">",
"      Evaluation of chronic pelvic pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/15/34039?source=related_link\">",
"      Evaluation of the adult with polyarticular pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/24/1418?source=related_link\">",
"      Evaluation of the patient with neck pain and cervical spine disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21146?source=related_link\">",
"      Overview of cancer pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11431?source=related_link\">",
"      Overview of craniofacial pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/46/1769?source=related_link\">",
"      Overview of electromyography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42778?source=related_link\">",
"      Overview of the treatment of chronic pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/12/23746?source=related_link\">",
"      Patient information: Chronic pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5450?source=related_link\">",
"      Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_22_40297="Psychotherapy for panic disorder";
var content_f39_22_40297=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psychotherapy for panic disorder",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40297/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40297/contributors\">",
"     Michelle Craske, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40297/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40297/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/22/40297/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/22/40297/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/22/40297/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H85592299\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Panic disorder with or without agoraphobia",
"    <span class=\"nowrap\">",
"     (PD/A)",
"    </span>",
"    is a common and chronic mental disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It is associated with high levels of social, occupational, and physical disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], considerable economic costs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/5-7\">",
"     5-7",
"    </a>",
"    ], and the highest number of medical visits among the anxiety disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/8\">",
"     8",
"    </a>",
"    ]. The modal age of onset is late teenage years and early adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/9\">",
"     9",
"    </a>",
"    ], although treatment is not usually sought until around 34 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The psychotherapy for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    with the most empirical support is cognitive behavioral therapy (CBT). CBT is based on a well-developed conceptualization of panic disorder as an acquired fear of certain bodily sensations, and agoraphobia as a behavioral response to the anticipation of such bodily sensations or their crescendo into a full-blown panic attack.",
"   </p>",
"   <p>",
"    This topic addresses psychotherapy for panic disorder. Pharmacotherapy for panic disorder is addressed separately. The epidemiology, pathogenesis, clinical manifestations, course, and diagnosis of panic disorder are addressed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7305?source=see_link\">",
"     \"Pharmacotherapy for panic disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157308639\">",
"    <span class=\"h1\">",
"     COGNITIVE BEHAVIORAL THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592311\">",
"    <span class=\"h2\">",
"     Theoretical foundation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive and behavioral theories generally conceptualize panic disorder as an acquired fear of bodily sensations, particularly sensations associated with autonomic arousal, in individuals with certain psychological and biological predispositions for the disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/11-14\">",
"     11-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23418139\">",
"    <span class=\"h3\">",
"     Panic attacks",
"    </span>",
"    &nbsp;&mdash;&nbsp;From an evolutionary standpoint, fear is a natural and adaptive response to threatening stimuli. However, an initial panic attack is often unjustified, or lacks an identifiable trigger, and hence represents a &ldquo;false alarm&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/13,15\">",
"     13,15",
"    </a>",
"    ]. After the occurrence of an unexpected panic attack, individual vulnerabilities such as neuroticism (or, emotionality) and anxiety sensitivity (or, beliefs that anxiety is harmful) seem to play a role in determining whether or not an individual then develops anxiety about further panic attacks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Furthermore, the anxiety typically becomes acutely focused on somatic sensations associated with panic attacks. As an example, individuals with",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    are particularly likely to become anxious during procedures that elicit sensations similar to those experienced during panic attacks, such as spinning in a circle, hyperventilating, and inhalations of carbon dioxide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Thus, procedures that reduce levels of CO",
"    <sub>",
"     2",
"    </sub>",
"    , as well as elevated levels of CO",
"    <sub>",
"     2",
"    </sub>",
"    , produce sensations that are feared by persons with panic disorder. These individuals also fear signals that ostensibly reflect heightened bodily arousal when given biofeedback to indicate changes in bodily state independent of actual changes in bodily state (ie, false physiological feedback) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], and over-attend to heart beat stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potential reasons for a patient&rsquo;s acute focus upon bodily sensations include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Interoceptive conditioning, or conditioned fear of internal cues such as elevated heart rate, due to their association with intense",
"      <span class=\"nowrap\">",
"       fear/distress",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/26\">",
"       26",
"      </a>",
"      ]. Low level somatic sensations become conditional stimuli such that early somatic symptoms of the anxious response come to elicit significant bursts of anxiety or panic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/27\">",
"       27",
"      </a>",
"      ]. Extensive research supports the robustness of interoceptive conditioning [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/28,29\">",
"       28,29",
"      </a>",
"      ] and the independence of interoceptive conditioned responses from conscious awareness of triggering cues [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/30\">",
"       30",
"      </a>",
"      ]. Hence, slight changes in somatic state that are not consciously recognized may elicit conditioned anxiety or panic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/15,27\">",
"       15,27",
"      </a>",
"      ], thus accounting for &ldquo;out of the blue&rdquo; panic attacks.",
"     </li>",
"     <li>",
"      Catastrophic appraisals of the bodily sensations as signs of imminent death, loss of control, or going crazy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/11\">",
"       11",
"      </a>",
"      ]. Persons with",
"      <span class=\"nowrap\">",
"       PD/A",
"      </span>",
"      endorse strong beliefs that bodily sensations associated with panic attacks cause physical or mental harm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/31\">",
"       31",
"      </a>",
"      ], selectively over-attend to words that represent physical and mental threat, such as &lsquo;disease&rsquo; and &lsquo;insane&rsquo; [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/32\">",
"       32",
"      </a>",
"      ], and show particularly rapid processing of panic-related words [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consequently, interoceptive conditioning",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    catastrophic appraisals lead the individual to become anxious in response to low level bodily sensations and the resultant anxious autonomic arousal intensifies the sensations, thus creating a reciprocating cycle of fear and sensations that builds into a panic attack. The perception of panic attacks as being unexpected or \"out of the blue\" generates even further anxiety in the long term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/34\">",
"     34",
"    </a>",
"    ]. The perceived uncontrollability, or inability to escape from or terminate bodily sensations, similarly is likely to generate further anxiety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/35\">",
"     35",
"    </a>",
"    ]. In turn, anxiety increases the likelihood of panic attacks, by directly increasing the availability of,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    attentional vigilance to, sensations that have become cues for panic. Thus, a maintaining cycle of panic and anxiety develops.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H557839771\">",
"    <span class=\"h3\">",
"     Avoidance behaviors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Avoidance behaviors, such as agoraphobia, are believed to maintain catastrophic beliefs about bodily sensations and interrupt natural extinction of conditioned fear of bodily sensations. Examples of avoidance include safety behaviors such as holding onto objects or persons due to fears of fainting, sitting and remaining still due to fears of heart attack, and moving slowly or searching for an escape due to fears of acting foolish [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/36\">",
"     36",
"    </a>",
"    ]. Avoidance also includes refusal to enter, or premature escape from, situations from which escape might be difficult or help unavailable in the event of panic-related sensations (such as driving, being far from home, and closed-in places).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157308710\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals for whom CBT works best are generally highly motivated and value a problem-solving approach. &nbsp;CBT requires that the patient learns the skills of self-observation and of becoming a personal scientist, learns cognitive and behavioral coping skills, and learns to repeatedly practice the skills in anxiety-provoking contexts outside of the therapy setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CBT as a general approach is heavily aligned with European and North American values of an individual&rsquo;s capacity for change, open self-disclosure, independence, autonomy, and rational thinking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/38\">",
"     38",
"    </a>",
"    ]. Such values often are at odds with values of harmony, family, and spirituality that are deeply embedded in Asian, Latino, Arabic, African American, and other cultures. Yet evidence suggests that CBT is effective with Latino and African American groups, and it is not clear whether cultural adaptation of the therapy (eg, greater involvement of family members) significantly improves the outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/39\">",
"     39",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Chronic life stress, or episodic stressful events, can also interfere with CBT for",
"    <span class=\"nowrap\">",
"     PD/A.",
"    </span>",
"    Relationship problems, job stress, financial hardship, and medical problems are examples of stressful situations that can both exacerbate panic symptoms and make it difficult for patients to engage in therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/40\">",
"     40",
"    </a>",
"    ]. In these situations, medication may be an option.",
"   </p>",
"   <p>",
"    Exposure, a behavioral intervention, may be contraindicated for persons with psychosis and other thought disorders or dementias, especially when behavioral avoidance of certain situations is adaptive for them. Since intensive exposure typically evokes high levels of anxiety at some point, it is generally not recommended when there are complicating medical conditions that make high levels of autonomic arousal potentially harmful (eg, certain arrhythmias or severe asthma). In some cases, a much more graduated exposure approach with ongoing monitoring of medical status may be an option.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592318\">",
"    <span class=\"h2\">",
"     Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;An in-depth semi- or fully structured interview is the first step in establishing diagnostic features and the profile of symptomatic and behavioral responses in preparation for psychotherapy. One example is the Anxiety Disorders Interview Schedule-Fourth Edition (ADIS-IV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/41\">",
"     41",
"    </a>",
"    ]. Data on the frequency, intensity, and duration of panic attacks, as well as details on avoidance behavior, are embedded within the ADIS-IV. Such information is particularly helpful for tailoring treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link&amp;anchor=H191515190#H191515190\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Assessment and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several standardized self-report inventories provide useful information for treatment planning, and are sensitive markers of therapeutic change:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anxiety Sensitivity Index, a trait measure of negative beliefs about bodily sensations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The Body Sensations and Agoraphobia Cognitions questionnaires provides more specific information about which particular bodily sensations are feared the most, and what specific misappraisals occur most often [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Mobility Inventory lists agoraphobic situations that are rated in terms of degree avoidance, when alone and when accompanied [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/44\">",
"       44",
"      </a>",
"      ]. This instrument is very useful for establishing the situations to be targeted for exposure therapy",
"     </li>",
"     <li>",
"      The Albany Panic and Phobia questionnaire assesses fear and avoidance of activities that produce feared bodily sensations, as well as more typical agoraphobia and social situations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Behavioral avoidance tests, in which patients are asked to complete as many or as much as they can of a series of anxiety provoking tasks, are particularly useful ways to gauge treatment progress. Anxiety levels are rated at regular intervals throughout the behavioral tests, and actual distance or length of time is measured. Tasks may involve exercises that induce panic-like symptoms, such as spinning in a circle, running in place, or hyperventilating [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/46\">",
"     46",
"    </a>",
"    ]. For agoraphobia, a behavioral test typically involves attempts at three to five situations that the patient identified before treatment as being from somewhat to extremely difficult (eg, driving two exits on a freeway, waiting in a bank line). Data from behavioral tests provide objective information that often differs from retrospective judgments as reported in self-report scales.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592325\">",
"    <span class=\"h2\">",
"     Principles of practice",
"    </span>",
"    &nbsp;&mdash;&nbsp;The central focus of CBT is teaching patients a set of cognitive and somatic coping skills to effectively manage their anxiety as they conduct repeated exposure to feared situations and sensations. More specifically, patients are taught to become personal observers of their panic, anxiety, and avoidance. They learn to implement skills of cognitive restructuring to replace catastrophic appraisals with more neutral and coping oriented appraisals, and skills of breathing retraining or relaxation to control dysregulated physiology. Next, patients are encouraged to apply the cognitive and somatic skills during exposure to feared bodily sensations and situations. Through repeated exposure, patients learn that panic-related sensations are not harmful, that panic and anxiety can be managed or tolerated, and that they are able to accomplish tasks that were previously avoided.",
"   </p>",
"   <p>",
"    Thus, the symptoms that CBT addresses are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Panic attacks",
"     </li>",
"     <li>",
"      Anxiety about panic attacks and related physical sensations",
"     </li>",
"     <li>",
"      Avoidance of sensations, including activities that induce sensations (eg, exercise) and situations in which panic attacks and related sensations are anticipated (eg, agoraphobia situations).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592332\">",
"    <span class=\"h2\">",
"     Specific techniques",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309048\">",
"    <span class=\"h3\">",
"     Education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment begins with education about the nature of",
"    <span class=\"nowrap\">",
"     PD/A,",
"    </span>",
"    the causes of panic and anxiety, and the way in which panic and anxiety are perpetuated by feedback loops among physical, cognitive and behavioral response systems. Specific descriptions of the psychophysiology of the fight-flight response are provided, as well as an explanation of the adaptive value of the various physiological changes that occur during panic and anxiety. The purpose of this education is to correct the common myths and misconceptions about panic symptoms (ie, beliefs about going crazy, dying or losing control) that contribute to panic and anxiety.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309062\">",
"    <span class=\"h3\">",
"     Self-monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-monitoring is introduced in the first treatment session and is continued throughout the entire treatment. Ongoing self-monitoring functions in two ways: it provides ongoing assessment of change in panic, anxiety, and avoidance; and acts as a therapeutic tool to encourage objective self awareness and increase accuracy in self observation. Patients are asked to keep at least two types of self-monitoring records:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A panic attack record, to be completed as soon as possible after each panic attack; this record provides a description of cues, maximal distress, and symptoms, thoughts and behaviors.",
"     </li>",
"     <li>",
"      A daily mood record, completed at the end of each day, to record overall or average levels of anxiety or depression. Patients may additionally keep a daily record of daily activities or situations avoided.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309069\">",
"    <span class=\"h3\">",
"     Breathing retraining",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breathing retraining is a commonly used somatic coping skill [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/47\">",
"     47",
"    </a>",
"    ]. It is supported by evidence of respiratory abnormalities in",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    possibly due to hypersensitive medullary carbon dioxide (CO2) detectors, resulting in hypocapnia (ie, lower than normal levels of PCO2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Traditional breathing retraining involves slow, abdominal breathing exercises. However, its value has been questioned in terms of the degree to which it actually corrects hypocapnic breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Capnometry-assisted respiratory training (CART) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/50,51\">",
"     50,51",
"    </a>",
"    ], in contrast to traditional breathing retraining, uses immediate feedback of end-tidal PCO2 to teach patients how to raise their subnormal levels of PCO2 (hyperventilation) and thereby gain control over dysfunctional respiratory patterns and associated panic symptoms (eg, shortness of breath, dizziness). CART has been shown to improve",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/51\">",
"     51",
"    </a>",
"    ] in part through reducing hypocapnic breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309084\">",
"    <span class=\"h3\">",
"     Muscle relaxation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another somatic coping skill is progressive muscle relaxation (PMR), in which patients are trained over a number of weeks in 16-muscle groups, 8-muscle groups, 4-muscle groups and finally cue-control relaxation, at which point relaxation is used as a coping skill for practicing exposure to items from a hierarchy of anxiety provoking tasks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309091\">",
"    <span class=\"h3\">",
"     Cognitive restructuring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Detailed self-monitoring of emotions and associated cognitions is used to identify specific beliefs, appraisals and assumptions. Relevant cognitions are categorized into types of errors, such as overestimations of risk of negative events, or catastrophizing of meaning of events. In labeling the type of cognitive distortion, the patient is encouraged to use an empirical approach to examine the validity of thoughts by considering all of the available evidence. Therapists use Socratic questioning to help patients make guided discoveries and question their anxious thoughts. Alternative hypotheses are generated that are more evidence-based. This approach is used to challenge surface level appraisals (such as &ldquo;my heart is racing dangerously too fast&rdquo;) and core beliefs or schemata (such as &ldquo;I am too weak to withstand distress&rdquo;) and develop more evidence-based appraisals and beliefs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309099\">",
"    <span class=\"h3\">",
"     Exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In vivo exposure involves repeated and systematic, real-life exposure to agoraphobic situations. It is intended to eventually reduce fear and avoidance of the situations through extinction of conditioned anxiety and correction of catastrophic misappraisals. Most often, in vivo exposure is conducted in a graduated manner, proceeding from the least to the most anxiety-provoking situations on an avoidance hierarchy, although there is some evidence to suggest that intensive or ungraduated exposure may also be effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Critical to in vivo exposure is lessening the patient&rsquo;s reliance on safety signals and safety behaviors. Common safety signals or behaviors can include the presence of other people, empty or full medication bottles, seeking reassurance, or checking for exits. Reliance on safety signals and safety behaviors attenuate distress in the short term but may maintain excessive anxiety in the long term. They are replaced by effective use of cognitive restructuring and somatic coping skills, with care to ensure that the coping skills themselves do not become alternative safety behaviors. In vivo exposure can be conducted with therapist guidance, followed by self-directed exposures between sessions (to enhance generalization of learning and to limit the therapist&rsquo;s role as a safety signal). &nbsp;",
"   </p>",
"   <p>",
"    In interoceptive exposure, the goal is to deliberately induce feared physical sensations a sufficient number of times and for long enough each time so that misappraisals about the sensations are disconfirmed and conditioned anxiety responding is extinguished. A standard list of exercises, such as hyperventilating and spinning, are used to establish a hierarchy of interoceptive exposures. Patients are encouraged to endure the sensations beyond the point at which they are first noticed, because early termination interferes with new learning. Interoceptive exposure usually is first conducted in-session with therapist guidance, followed by self-directed practice between sessions. Interoceptive exposure extends to routine activities that inherently induce somatic sensations (eg, caffeine consumption, exercise programs). Eventually, in vivo exposure is combined with interoceptive exposure, by deliberately inducing feared sensations in feared situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309120\">",
"    <span class=\"h3\">",
"     Relapse prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;A final step of CBT is relapse prevention, in which patients are informed that despite their progress, recurrences of panic, anxiety or avoidance behavior are likely to occur in the future. They are encouraged to view such recurrences as lapses rather than failure, and to reapply their coping skills and reinstitute their practice of interoceptive and in vivo exposure. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592353\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a meta-analysis of five randomized trials of 328 patients with",
"    <span class=\"nowrap\">",
"     PD/A,",
"    </span>",
"    CBT has been found to be efficacious in comparison to a pill placebo or psychological control condition (odds ratio = 2.5, 95% CI: 1.2 to 5.4) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/54\">",
"     54",
"    </a>",
"    ]. Other systematic reviews and meta-analyses have come to similar conclusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. CBT has a large overall within-group effect size for symptom reduction from pre to post-treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/55\">",
"     55",
"    </a>",
"    ] and a substantial between-group effect size (eg, ES=.64) in comparison to wait list control groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical trials have generally shown CBT&rsquo;s effects to be sustained over time, with little decrease in gains at 6 to 12 month follow-up assessments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. A review of meta-analyses for CBT across disorders concluded that evidence for maintenance of treatment gains was particularly strong for panic disorder, where the rate of relapse was almost half the rate of relapse following pharmacotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/58\">",
"     58",
"    </a>",
"    ]. Continuing improvement after acute treatment is facilitated by involvement of significant others in every aspect of treatment for agoraphobia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/59\">",
"     59",
"    </a>",
"    ]. Also, booster sessions have been shown to enhance long-term outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Efficacy data from research settings are now being complemented by effectiveness data from real world, primary care settings. A randomized trial of 232 primary care patients with",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    compared usual care to an intervention consisting of CBT delivered by novice therapists who received CBT training, algorithm-based pharmacotherapy provided by primary care physicians with guidance from a psychiatrist, and care coordination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/61\">",
"     61",
"    </a>",
"    ]. The intervention resulted in higher rates of response (46 versus 27 percent) and remission (20 versus 12 percent), respectively, than usual care. Treatment effects appeared primarily due to CBT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/62\">",
"     62",
"    </a>",
"    ]. A more recent effectiveness trial of the intervention, Coordinated Anxiety Learning and Management (CALM), showed similarly favorable results for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    in primary care settings compared to treatment as usual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although CBT can be effective for many patients, a substantial number experience inadequate results. One study estimated that 30 percent of patients continue to function poorly at follow-up following CBT and only 48 percent had minimal or no symptoms of panic, anxiety and avoidance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/65\">",
"     65",
"    </a>",
"    ]. Of patients who start CBT for",
"    <span class=\"nowrap\">",
"     PD/A,",
"    </span>",
"    the mean drop-out rate is 19 percent in clinical trials with a range of 0 to 54 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of clinical trials indicate that self-guided or minimal therapist contact CBT for",
"    <span class=\"nowrap\">",
"     PD/A,",
"    </span>",
"    by workbook [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/66\">",
"     66",
"    </a>",
"    ] and by internet are efficacious [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592367\">",
"    <span class=\"h2\">",
"     Predictors of better outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite relatively high rates of comorbidity between",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    and other anxiety or mood disorders, most comorbidities do not appear to reduce the effectiveness of CBT for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/57,69,70\">",
"     57,69,70",
"    </a>",
"    ]. The evidence for an impact of comorbid depression on CBT&rsquo;s effectiveness for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    is mixed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/57,70-73\">",
"     57,70-73",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link&amp;anchor=H191515149#H191515149\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A relatively high co-occurrence exists between",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    and avoidant, dependent, and histrionic personality disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/74\">",
"     74",
"    </a>",
"    ]. Comorbid personality disorders are sometimes associated with poorer response than usual to CBT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. However, closer examination reveals that comorbid patients start and end at a higher level of severity, but that their rate of decrease in",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    symptoms is similar to those without comorbidity, suggesting that the presence of a comorbid personality disorder may warrant a longer CBT regimen than is typical [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H157309191\">",
"     'Frequency and duration of treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Medical comorbidity, such as cardiac arrhythmias or asthma, may slow improvement rates. Potential complications include discriminating anxiety symptomatology from disease symptomatology, increases in actual medical risk, and the stress of physical diseases. However, the effect of medical comorbidity upon CBT outcome has not been assessed to date, and attempts to modify CBT to address medical comorbidity are only just emerging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/80\">",
"     80",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=see_link&amp;anchor=H1043138#H1043138\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Medical comorbidity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Attrition from CBT is predicted by lower education and socioeconomic status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Low",
"    <span class=\"nowrap\">",
"     education/income",
"    </span>",
"    may reflect less discretionary time to engage in activities such as weekly treatment. Another predictor of attrition was attribution of the disorder to specific life stressors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/81\">",
"     81",
"    </a>",
"    ], perhaps because such individuals saw the offered treatment as irrelevant.",
"   </p>",
"   <p>",
"    Patient compliance with CBT homework assignments is positively correlated with treatment outcomes across disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/83\">",
"     83",
"    </a>",
"    ] and in",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    specifically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157309191\">",
"    <span class=\"h2\">",
"     Frequency and duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies of CBT for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    involve 10 to 20 weekly treatment sessions, conducted either one-on-one or in small groups, for 60 to 120 minutes per session. Positive results have been reported with as few as four sessions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/85\">",
"     85",
"    </a>",
"    ] and six sessions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/61,86\">",
"     61,86",
"    </a>",
"    ], and with intensive treatment over two days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/87\">",
"     87",
"    </a>",
"    ]. However, one study reported greater improvement with more sessions attended out of a total of six full therapy sessions and six follow-up booster phone calls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CBT treatment sessions are always accompanied by homework assignments, usually daily, to be conducted between sessions. Thus, therapy time for the patient is more extensive than the time spent in-session with therapists. (See",
"    <a class=\"local\" href=\"#H85592367\">",
"     'Predictors of better outcome'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H898870663\">",
"    <span class=\"h2\">",
"     Comparing CBT to medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;CBT and antidepressant medication have been shown in controlled trials to be equally effective in the treatment of panic disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/88\">",
"     88",
"    </a>",
"    ]. A meta-analysis of 11 trials that compared CBT with antidepressants found that the two interventions led to similarly improved response rates and reductions in global anxiety and depression, with neither intervention showing an advantage over the other. Trials have suggested that patients completing a course of CBT are less likely to experience relapse in the year following treatment compared to patients who were treated with medication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/58,89\">",
"     58,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CBT, pharmacotherapy, or a combination of the two are reasonable choices for initial treatment of",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    without extensive comorbidity or suicidality. Selection among them can be made on the basis of patient preference and treatment availability.",
"   </p>",
"   <p>",
"    Patients who do not achieve optimal outcomes at completion of a course of CBT have been shown to respond better to a trial of pharmacotherapy compared to receiving further CBT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/90\">",
"     90",
"    </a>",
"    ]. Conversely, individuals who are resistant to pharmacotherapy may respond positively to CBT, although these findings were part of an uncontrolled study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/91\">",
"     91",
"    </a>",
"    ]. Many more patients receive medications than CBT for",
"    <span class=\"nowrap\">",
"     PD/A,",
"    </span>",
"    partly because primary care physicians are usually the first line of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A simulation model drawing on epidemiologic and efficacy data found CBT may be more cost effective than pharmacotherapy for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    when including both direct and indirect costs (eg, disability costs, work days missed, health care use) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H69301556\">",
"    <span class=\"h2\">",
"     Combined CBT and medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of CBT (or in some cases behavioral therapy) and antidepressant treatment has shown a small advantage over either CBT alone or antidepressants alone for",
"    <span class=\"nowrap\">",
"     PD/A.",
"    </span>",
"    A meta-analysis of 21 trials with 1709 patients compared either CBT or antidepressant treatment for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    to combined CBT-antidepressant treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/94\">",
"     94",
"    </a>",
"    ]. Combined treatment was superior to antidepressant pharmacotherapy (RR 1.24, 95% CI 1.02 to 1.52) or psychotherapy (RR 1.17, 95% CI 1.05 to 1.31). Combined treatment resulted in a somewhat greater number of patient dropouts due to side effects than psychotherapy alone. The superiority of the combination over either monotherapy appeared to persist as long as the drug was continued. Following discontinuation of the antidepressant, the groups initially assigned to either combined treatment or CBT did better than patients assigned to pharmacotherapy.",
"   </p>",
"   <p>",
"    A randomized effectiveness trial in the primary care setting compared combined pharmacotherapy and CBT to usual care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/62\">",
"     62",
"    </a>",
"    ]. The addition of even one component of CBT to medications for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    resulted in clinically meaningful improvement following treatment, and 12 months later.",
"   </p>",
"   <p>",
"    We suggest the use of combined treatment for patients with",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    with comorbid posttraumatic stress disorder, depression, or suicidality. This suggestion is based upon our clinical experience; there is no evidence on response to combined versus individual treatments specific to these subgroups. Combined treatment should also be offered to patients with persistent symptoms following adequate treatment with either monotherapy.",
"   </p>",
"   <p>",
"    Findings from the combination of high potency benzodiazepines with behavioral treatments for agoraphobia are mixed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/95,96\">",
"     95,96",
"    </a>",
"    ]. Several studies reliably show that chronic use of high potency benzodiazepines for",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    have detrimental effects on short and long-term outcomes from CBT, including more attrition, less improvement, and greater likelihood of relapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/96-98\">",
"     96-98",
"    </a>",
"    ]. In addition, use of benzodiazepines &ldquo;as needed&rdquo; in addition to CBT was associated with poorer outcomes than routine daily dosing or no use of benzodiazepines, in one small uncontrolled study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/99\">",
"     99",
"    </a>",
"    ]. CBT combined with tapering the medication dose can be an effective strategy for discontinuation of benzodiazepines in difficult cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H85592381\">",
"    <span class=\"h1\">",
"     OTHER PSYCHOTHERAPIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157307925\">",
"    <span class=\"h2\">",
"     Psychodynamic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Results from one well-designed randomized trial suggest that brief psychodynamic therapy may be effective for panic disorder and agoraphobia, but replication of the trial is needed. The trial compared a manualized, panic-focused psychodynamic therapy to an applied relaxation control condition in 49 patients with panic disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. Both interventions were delivered twice weekly for 12 weeks. The psychodynamic therapy resulted in a greater rate of symptom response than the relaxation therapy (73 versus 39 percent). A secondary outcome, psychosocial functioning, showed a similar result.",
"   </p>",
"   <p>",
"    Other studies of psychodynamic therapy have had significant limitations: small size, nonrandom assignment, lack of an inactive control group, or studied psychodynamic therapy only in combination with another intervention:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A non-randomized trial of 46 patients with panic disorder compared psychodynamic therapy to systematic desensitization (ie, imaginal exposure to feared situations combined with relaxation training). Both groups experienced a reduction in agoraphobia fear; neither intervention showed an advantage over the other [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/103\">",
"       103",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A trial of 35 patients with a mean 7-year history of agoraphobia found that the combination of behavioral therapy and psychodynamic therapy was more effective for reducing symptoms of agoraphobia than a wait-list control [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/104\">",
"       104",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a trial of 20 patients with agoraphobia treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      , patients were randomly assigned to 15 weekly sessions of psychodynamic therapy or to continued medication alone. Patients receiving psychotherapy were less likely to experience a relapse [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/105\">",
"       105",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A trial of 19 inpatients with agoraphobia found that psychodynamic therapy and an integrated behavioral and psychodynamic therapy were both associated with significant improvements. However, the integrated therapy was more effective than psychodynamic therapy at 12-month follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/106\">",
"       106",
"      </a>",
"      ]. This study was limited by a lack of manualization (and therefore replicability) of the therapies and lack of independent outcome assessment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is need for more research on the value of brief psychodynamic therapy and its effectiveness in comparison to cognitive behavioral therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H157308463\">",
"    <span class=\"h2\">",
"     Acceptance-based approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another psychotherapy approach that is gaining interest emphasizes &lsquo;acceptance&rsquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/107\">",
"     107",
"    </a>",
"    ]. This approach involves:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Detecting and challenging experiential avoidance and encouraging awareness of moment to moment experience. Rather than attempting to change internal states (eg, catastrophic misappraisals and bodily sensations), acceptance involves nonjudgmental observing of those states.",
"     </li>",
"     <li>",
"      Defusion techniques (such as mindfulness) are used so that patients learn to observe and accept rather than seek to change their internal states. Mindfulness involves observation of moment to moment experience. &nbsp;Defusion techniques contrast with cognitive restructuring and somatic coping skills of CBT, which aim to directly change catastrophic thinking and bodily states.",
"      <br/>",
"      <br/>",
"      Another element is flexible and open exposure to previously avoided events. This element of acceptance-based approaches is somewhat consistent with exposure therapy in CBT, although in CBT, exposure is accompanied by cognitive and somatic coping skills whereas in acceptance, exposure is encouraged without the use of coping skills.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although there are some similarities between an acceptance approach and a CBT approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/108\">",
"     108",
"    </a>",
"    ], acceptance does not involve any form of cognitive restructuring (ie, identifying, challenging and replacing negative thinking with more realistic thinking), or any attempt to change or correct somatic dysregulation (eg, breathing retraining). Acceptance approaches are part of Acceptance and Commitment Therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/109\">",
"     109",
"    </a>",
"    ] and Mindfulness Based Stress Reduction (MBSR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Empirical evidence for the efficacy of acceptance approaches for the treatment of",
"    <span class=\"nowrap\">",
"     PD/A",
"    </span>",
"    is limited to one small, uncontrolled trial of MBSR that showed reductions of anxiety, depression, and panic attacks, which were maintained at a three-year follow up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/22/40297/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. Further research is needed on the efficacy of acceptance approaches to",
"    <span class=\"nowrap\">",
"     PD/A.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/10/13473?source=see_link\">",
"       \"Patient information: Panic disorder (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H898870914\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend cognitive behavioral therapy (CBT), a selective serotonergic reuptake inhibitor (SSRI) antidepressant, or a combination of the two as initial treatment for panic disorder (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Selection among them can be made on the basis of patient preference and the availability of therapists providing CBT. (See",
"      <a class=\"local\" href=\"#H85592353\">",
"       'Efficacy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H898870663\">",
"       'Comparing CBT to medication'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7305?source=see_link\">",
"       \"Pharmacotherapy for panic disorder\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CBT and SSRIs have been shown to reduce",
"      <span class=\"nowrap\">",
"       PD/A",
"      </span>",
"      symptoms to a comparable extent, although relapse rates following discontinuation of treatment may be higher for medications than CBT.",
"     </li>",
"     <li>",
"      We suggest the use of combined CBT and SSRIs for patients with",
"      <span class=\"nowrap\">",
"       PD/A",
"      </span>",
"      and comorbid post-traumatic stress disorder, depression, or suicidality (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This suggestion is based on our clinical experience; there is no evidence on response to combined versus individual treatments specific to these subgroups. Combined treatment should also be offered to patients with persistent symptoms following adequate treatment with either monotherapy. (See",
"      <a class=\"local\" href=\"#H69301556\">",
"       'Combined CBT and medication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cognitive and behavioral theories underlying CBT generally conceptualize panic disorder as an acquired fear of bodily sensations, particularly sensations associated with autonomic arousal, in individuals with certain psychological and biological predispositions for the disorder. (See",
"      <a class=\"local\" href=\"#H85592311\">",
"       'Theoretical foundation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals for whom CBT works best are generally highly motivated and value a problem-solving approach, because CBT requires that the patient learns the skills of self-observation and of becoming a personal scientist, learns cognitive and behavioral coping skills, and learns to repeatedly practice the skills in anxiety-provoking contexts outside of the therapy setting. (See",
"      <a class=\"local\" href=\"#H157308710\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific techniques comprising CBT typically include education, self-monitoring, breathing retraining, muscle relaxation, cognitive restructuring, exposure, and relapse prevention. (See",
"      <a class=\"local\" href=\"#H85592332\">",
"       'Specific techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CBT is typically provided for",
"      <span class=\"nowrap\">",
"       PD/A",
"      </span>",
"      over 10 to 20 weekly treatment sessions, conducted either one-on-one or in small groups, for 60 to 120 minutes per session. Clinical trials have generally shown CBT&rsquo;s effects to be sustained over time, with little decrease in gains at 6 to 12 month follow-up assessments. Booster sessions have been shown to enhance long-term outcomes. (See",
"      <a class=\"local\" href=\"#H85592353\">",
"       'Efficacy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H157309191\">",
"       'Frequency and duration of treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who do not achieve optimal outcomes at completion of either CBT or pharmacotherapy can be considered for a trial of the other modality. Patients who do not fully respond to CBT have been shown to respond better to a trial of pharmacotherapy than to further CBT. Data in support of pharmacotherapy among patients resistant to CBT is limited to a single uncontrolled trial. (See",
"      <a class=\"local\" href=\"#H898870663\">",
"       'Comparing CBT to medication'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/1\">",
"      Katschnig H, Amering M. The long-term course of panic disorder and its predictors. J Clin Psychopharmacol 1998; 18:6S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/2\">",
"      Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/3\">",
"      Klerman GL, Weissman MM, Ouellette R, et al. Panic attacks in the community. Social morbidity and health care utilization. JAMA 1991; 265:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/4\">",
"      Keller MB, Yonkers KA, Warshaw MG, et al. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J Nerv Ment Dis 1994; 182:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/5\">",
"      Leon AC, Portera L, Weissman MM. The social costs of anxiety disorders. Br J Psychiatry Suppl 1995; :19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/6\">",
"      Roy-Byrne PP, Stein MB, Russo J, et al. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry 1999; 60:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/7\">",
"      Katon W, Von Korff M, Lin E, et al. Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990; 12:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/8\">",
"      Deacon B, Lickel J, Abramowitz JS. Medical utilization across the anxiety disorders. J Anxiety Disord 2008; 22:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/9\">",
"      Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/10\">",
"      Noyes R Jr, Crowe RR, Harris EL, et al. Relationship between panic disorder and agoraphobia. A family study. Arch Gen Psychiatry 1986; 43:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/11\">",
"      Clark DM. A cognitive approach to panic. Behav Res Ther 1986; 24:461.",
"     </a>",
"    </li>",
"    <li>",
"     Ehlers, A, Margraf, J. The psychophysiological model of panic attacks. In: Fresh Perspectives on Anxiety Disorders, Emmelkamp, PMG, Everaerd, W, Kraaimaat, F, van Sons, M (Eds), Swets &amp; Zeitlinger, Amsterdam 1989.",
"    </li>",
"    <li>",
"     Barlow, D. Anxiety and its disorders: The nature and treatment of anxiety and panic, 2nd ed, Guilford Press, New York 2002.",
"    </li>",
"    <li>",
"     Craske, M. The origins of phobias and anxiety disorders: Why more women than men?, Elsevier Science, Oxford 2003.",
"    </li>",
"    <li>",
"     Barlow, D. Office-based behavioural treatment of panic attack. In: Panic Disorder: Relative merits of pharmacotherapy and psychotherapy, The Medicine Group, Ontario 1988. p.6.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/16\">",
"      Hayward C, Killen JD, Kraemer HC, Taylor CB. Predictors of panic attacks in adolescents. J Am Acad Child Adolesc Psychiatry 2000; 39:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/17\">",
"      Ehlers A. A 1-year prospective study of panic attacks: clinical course and factors associated with maintenance. J Abnorm Psychol 1995; 104:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/18\">",
"      Schmidt NB, Lerew DR, Jackson RJ. The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. J Abnorm Psychol 1997; 106:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/19\">",
"      Schmidt NB, Lerew DR, Jackson RJ. Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. J Abnorm Psychol 1999; 108:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/20\">",
"      Antony MM, Ledley DR, Liss A, Swinson RP. Responses to symptom induction exercises in panic disorder. Behav Res Ther 2006; 44:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/21\">",
"      Gorman JM, Papp LA, Coplan JD, et al. Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. Am J Psychiatry 1994; 151:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/22\">",
"      Perna G, Gabriele A, Caldirola D, Bellodi L. Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res 1995; 57:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/23\">",
"      Craske MG, Lang AJ, Rowe M, et al. Presleep attributions about arousal during sleep: nocturnal panic. J Abnorm Psychol 2002; 111:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/24\">",
"      Ehlers A, Margraf J, Roth WT, et al. Anxiety induced by false heart rate feedback in patients with panic disorder. Behav Res Ther 1988; 26:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/25\">",
"      Kroeze S, van den Hout MA. Selective attention for cardiac information in panic patients. Behav Res Ther 2000; 38:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/26\">",
"      RAZRAN G. The observable unconscious and the inferable conscious in current Soviet psychophysiology: interoceptive conditioning, semantic conditioning, and the orienting reflex. Psychol Rev 1961; 68:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/27\">",
"      Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 2001; 108:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/28\">",
"      Dworkin BR, Dworkin S. Heterotopic and homotopic classical conditioning of the baroreflex. Integr Physiol Behav Sci 1999; 34:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/29\">",
"      Sokolowska M, Siegel S, Kim JA. Intraadministration associations: conditional hyperalgesia elicited by morphine onset cues. J Exp Psychol Anim Behav Process 2002; 28:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/30\">",
"      Block RI, Ghoneim MM, Fowles DC, et al. Effects of a subanesthetic concentration of nitrous oxide on establishment, elicitation, and semantic and phonemic generalization of classically conditioned skin conductance responses. Pharmacol Biochem Behav 1987; 28:7.",
"     </a>",
"    </li>",
"    <li>",
"     Clark, D. A cognitive model of panic attacks. In: Psychological perspectives, Rachman, S, Maser, J (Eds), Lawrence Eribaum Associates, Inc, Hillsdale 1988. p.71.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/32\">",
"      Teachman BA, Smith-Janik SB, Saporito J. Information processing biases and panic disorder: relationships among cognitive and symptom measures. Behav Res Ther 2007; 45:1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/33\">",
"      Pauli P, Amrhein C, M&uuml;hlberger A, et al. Electrocortical evidence for an early abnormal processing of panic-related words in panic disorder patients. Int J Psychophysiol 2005; 57:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/34\">",
"      Craske MG, Glover D, DeCola J. Predicted versus unpredicted panic attacks: acute versus general distress. J Abnorm Psychol 1995; 104:214.",
"     </a>",
"    </li>",
"    <li>",
"     Maier, S, Laudenslager, M, Ryan, S. Stressor controllability, immune function, and endogenous opiates. In: Affect, conditioning, and cognition: Essays on the determinants of behavior, Brush, F, Overmier, J (Eds), Erlbaum, Hillsdale 1985. p.183.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/36\">",
"      Salkovskis PM, Clark DM, Gelder MG. Cognition-behaviour links in the persistence of panic. Behav Res Ther 1996; 34:453.",
"     </a>",
"    </li>",
"    <li>",
"     Craske, M. Cognitive behavior therapy, American Psychological Association, Washington, DC 2009.",
"    </li>",
"    <li>",
"     Hays, P, Iwamasa, G. Culturally responsive cognitive behavioral therapy: Assessment, practice, and supervision, American Psychological Association, Washington, DC 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/39\">",
"      Miranda J, Bernal G, Lau A, et al. State of the science on psychosocial interventions for ethnic minorities. Annu Rev Clin Psychol 2005; 1:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/40\">",
"      Sanderson, W, Bruce, T. Causes and management of treatment-resistant panic disorder and agoraphobia: A survey of expert therapists. Cogn Behav Pract 2007; 14:26.",
"     </a>",
"    </li>",
"    <li>",
"     DiNardo, P, Brown, T, Barlow, D. Anxiety Disorders Interview Schedule for DSM-IV: Life Version (ADIS-IV-L), Graywind Publications, Albany, NY 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/42\">",
"      Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 1986; 24:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/43\">",
"      Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984; 52:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/44\">",
"      Chambless DL, Caputo GC, Jasin SE, et al. The Mobility Inventory for Agoraphobia. Behav Res Ther 1985; 23:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/45\">",
"      Rapee RM, Craske MG, Barlow DH. Assessment instrument for panic disorder that includes fear of sensation-producing activities: the Albany Panic and Phobia Questionnaire. Anxiety 1994; 1:114.",
"     </a>",
"    </li>",
"    <li>",
"     Barlow, D, Craske, M. Mastery of your anxiety and panic, 4th ed, Oxford University Press, New York 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/47\">",
"      Barlow, D, Craske, M, Cerny, J, Klosko, J. Behavioral treatment of panic disorder. Behav Ther 1989; 20:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/48\">",
"      Caldirola D, Bellodi L, Caumo A, et al. Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry 2004; 161:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/49\">",
"      Garssen, B, de, Ruiter, C, van, Dyck, R. Breathing retraining: A rational placebo? Clin Psychol Rev 1992; 12:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/50\">",
"      Meuret AE, Wilhelm FH, Roth WT. Respiratory biofeedback-assisted therapy in panic disorder. Behav Modif 2001; 25:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/51\">",
"      Meuret AE, Wilhelm FH, Ritz T, Roth WT. Feedback of end-tidal pCO2 as a therapeutic approach for panic disorder. J Psychiatr Res 2008; 42:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/52\">",
"      Meuret AE, Rosenfield D, Seidel A, et al. Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity. J Consult Clin Psychol 2010; 78:691.",
"     </a>",
"    </li>",
"    <li>",
"     Feigenbaum, W. Long-term efficacy of ungraded versus graded massed exposure in agoraphobics. In: Panic and phobias: Treatments and variables affecting course and outcome, Hand, I, Wittchen, H (Eds), Springer-Verlag, Berlin 1988. p.87.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/54\">",
"      Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 2008; 69:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/55\">",
"      Norton PJ, Price EC. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 2007; 195:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/56\">",
"      Haby MM, Donnelly M, Corry J, Vos T. Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Aust N Z J Psychiatry 2006; 40:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/57\">",
"      Brown TA, Antony MM, Barlow DH. Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment. J Consult Clin Psychol 1995; 63:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/58\">",
"      Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006; 26:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/59\">",
"      Cerny J, Barlow D, Craske M, Himaldi W. Couples treatment of agoraphobia: A two-year follow-up. Behav Ther 1987; 18:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/60\">",
"      Craske MG, Roy-Byrne P, Stein MB, et al. CBT intensity and outcome for panic disorder in a primary care setting. Behav Ther 2006; 37:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/61\">",
"      Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005; 62:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/62\">",
"      Craske MG, Golinelli D, Stein MB, et al. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting? Psychol Med 2005; 35:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/63\">",
"      Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010; 303:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/64\">",
"      Craske MG, Stein MB, Sullivan G, et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry 2011; 68:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/65\">",
"      Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995; 63:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/66\">",
"      Schneider AJ, Mataix-Cols D, Marks IM, Bachofen M. Internet-guided self-help with or without exposure therapy for phobic and panic disorders. Psychother Psychosom 2005; 74:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/67\">",
"      Spek V, Cuijpers P, Nykl&iacute;cek I, et al. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med 2007; 37:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/68\">",
"      Andrews G, Cuijpers P, Craske MG, et al. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One 2010; 5:e13196.",
"     </a>",
"    </li>",
"    <li>",
"     Allen, L, Barlow, D. Treatment of panic disorder: outcomes and basic processes. In: Pathological anxiety: Emotional processing in etiology and treatment, Rothbaum, B (Eds), Guilford Press, New York 2006. p.166.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/70\">",
"      McLean PD, Woody S, Taylor S, Koch WJ. Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy. J Consult Clin Psychol 1998; 66:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/71\">",
"      Laberge B, Gauthier JG, C&ocirc;t&eacute; G, et al. Cognitive-behavioral therapy of panic disorder with secondary major depression: a preliminary investigation. J Consult Clin Psychol 1993; 61:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/72\">",
"      Maddock RJ, Blacker KH. Response to treatment in panic disorder with associated depression. Psychopathology 1991; 24:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/73\">",
"      Wade WA, Treat TA, Stuart GL. Transporting an empirically supported treatment for panic disorder to a service clinic setting: a benchmarking strategy. J Consult Clin Psychol 1998; 66:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/74\">",
"      Reich J, Perry JC, Shera D, et al. Comparison of personality disorders in different anxiety disorder diagnoses: panic, agoraphobia, generalized anxiety, and social phobia. Ann Clin Psychiatry 1994; 6:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/75\">",
"      Hoffart A, Hedley LM. Personality traits among panic disorder with agoraphobia patients before and after symptom-focused treatment. J Anxiety Disord 1997; 11:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/76\">",
"      Marchand, A, Goyer, L, Dupuis, G, Mainguy, N. Personality disorders and the outcome of cognitive-behavioral treatment of panic disorder with agoraphobia. Can J Behav Sci 1998; 30:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/77\">",
"      Dreessen L, Arntz A, Luttels C, Sallaerts S. Personality disorders do not influence the results of cognitive behavior therapies for anxiety disorders. Compr Psychiatry 1994; 35:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/78\">",
"      van den, Hout M, Brouwers C, Oomen J. Clinically diagnosed Axis II comorbidity and the short term outcome of CBT for Axis I disorders. Clin Psychol Psychother 2006; 13:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/79\">",
"      Hofmann SG, Barlow DH, Papp LA, et al. Pretreatment attrition in a comparative treatment outcome study on panic disorder. Am J Psychiatry 1998; 155:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/80\">",
"      Lehrer PM, Karavidas MK, Lu SE, et al. Psychological treatment of comorbid asthma and panic disorder: a pilot study. J Anxiety Disord 2008; 22:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/81\">",
"      Grilo CM, Money R, Barlow DH, et al. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry 1998; 39:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/82\">",
"      Keijsers, G, Kampman, M, Hoogduin, C. Dropout prediction in cognitive behavior therapy for panic disorder. Behav Ther  2001; 32:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/83\">",
"      Kazantzis N, Ronan KR, Deane FP. Concluding causation from correlation: comment on Burns and Spangler (2000). J Consult Clin Psychol 2001; 69:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/84\">",
"      Schmidt NB, Woolaway-Bickel K. The effects of treatment compliance on outcome in cognitive-behavioral therapy for panic disorder: quality versus quantity. J Consult Clin Psychol 2000; 68:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/85\">",
"      Craske MG, Maidenberg E, Bystritsky A. Brief cognitive-behavioral versus nondirective therapy for panic disorder. J Behav Ther Exp Psychiatry 1995; 26:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/86\">",
"      Clark DM, Salkovskis PM, Hackmann A, et al. Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol 1999; 67:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/87\">",
"      Deacon B, Abramowitz J. A pilot study of two-day cognitive-behavioral therapy for panic disorder. Behav Res Ther 2006; 44:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/88\">",
"      Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005; 88:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/89\">",
"      Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 2000; 283:2529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/90\">",
"      Kampman M, Keijsers GP, Hoogduin CA, Hendriks GJ. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. J Clin Psychiatry 2002; 63:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/91\">",
"      Heldt E, Blaya C, Isolan L, et al. Quality of life and treatment outcome in panic disorder: cognitive behavior group therapy effects in patients refractory to medication treatment. Psychother Psychosom 2006; 75:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/92\">",
"      Wang PS, Berglund P, Olfson M, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/93\">",
"      Heuzenroeder L, Donnelly M, Haby MM, et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust N Z J Psychiatry 2004; 38:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/94\">",
"      Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev 2007; :CD004364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/95\">",
"      Marks IM, Ba��o��lu M, Noshirvani H, et al. Drug treatment of panic disorder. Further comment. Br J Psychiatry 1993; 162:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/96\">",
"      Wardle J, Hayward P, Higgitt A, et al. Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia. Behav Res Ther 1994; 32:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/97\">",
"      Otto, M, Pollack, M, Sabatino, S. Maintenance of remission following cognitive-behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment. Behav Ther 1996; 27:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/98\">",
"      van Balkom AJ, de Beurs E, Koele P, et al. Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia. J Nerv Ment Dis 1996; 184:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/99\">",
"      Westra HA, Stewart SH, Conrad BE. Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia. J Anxiety Disord 2002; 16:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/100\">",
"      Otto MW, Pollack MH, Sachs GS, et al. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 1993; 150:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/101\">",
"      Milrod B, Leon AC, Busch F, et al. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 2007; 164:265.",
"     </a>",
"    </li>",
"    <li>",
"     Milrod, B, Busch, F, Cooper, A, Shapiro, T. Manual of panic-focused psychodynamic psychotherapy, American Psychiatric Press, Washington, DC 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/103\">",
"      Gelder MG, Marks IM, Wolff HH. Desensitization and psychotherapy in the treatment of phobic states: a controlled inquiry. Br J Psychiatry 1967; 113:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/104\">",
"      Chambless, D, Goldstein, A, Gallagher, R, Bright, P. Integrating behavior therapy and psychotherapy in the treatment of agoraphobia. Psychotherapy 1986; 23:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/105\">",
"      Wiborg IM, Dahl AA. Does brief dynamic psychotherapy reduce the relapse rate of panic disorder? Arch Gen Psychiatry 1996; 53:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/106\">",
"      Hoffart, A, Martinsen, E. Exposure-based integrated vs. pure psychodynamic treatment of agoraphobic inpatients. Psychotherapy 1990; 27:210.",
"     </a>",
"    </li>",
"    <li>",
"     Hayes, S, Pankey, J. Acceptance. In: Cognitive behavior therapy: Applying empirically supported techniques in your practice, O&rsquo;Donohue, W, Fisher, J, Hayes, S (Eds), John Wiley &amp; Sons, Hoboken, NJ 2003. p.4.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/108\">",
"      Arch, J, Craske, M. ACT and CBT for anxiety disorders: Different treatments, similar mechanisms? Clin Psychol 2008; 15:263.",
"     </a>",
"    </li>",
"    <li>",
"     Hayes, S, Strosahl, K, Wilson, K. Acceptance and commitment therapy: An experiential approach to behavior change, Guilford Press, New York 1999.",
"    </li>",
"    <li>",
"     Kabat-Zinn, J. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness, Delta, New York 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/111\">",
"      Kabat-Zinn J, Massion AO, Kristeller J, et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992; 149:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/22/40297/abstract/112\">",
"      Miller JJ, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry 1995; 17:192.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14633 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-9F549ED38C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40297=[""].join("\n");
var outline_f39_22_40297=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H898870914\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H85592299\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H157308639\">",
"      COGNITIVE BEHAVIORAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H85592311\">",
"      Theoretical foundation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23418139\">",
"      - Panic attacks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H557839771\">",
"      - Avoidance behaviors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H157308710\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H85592318\">",
"      Assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H85592325\">",
"      Principles of practice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H85592332\">",
"      Specific techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309048\">",
"      - Education",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309062\">",
"      - Self-monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309069\">",
"      - Breathing retraining",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309084\">",
"      - Muscle relaxation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309091\">",
"      - Cognitive restructuring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309099\">",
"      - Exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H157309120\">",
"      - Relapse prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H85592353\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H85592367\">",
"      Predictors of better outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H157309191\">",
"      Frequency and duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H898870663\">",
"      Comparing CBT to medication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H69301556\">",
"      Combined CBT and medication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H85592381\">",
"      OTHER PSYCHOTHERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H157307925\">",
"      Psychodynamic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H157308463\">",
"      Acceptance-based approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H898870914\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44713?source=related_link\">",
"      Panic disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/10/13473?source=related_link\">",
"      Patient information: Panic disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7305?source=related_link\">",
"      Pharmacotherapy for panic disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_22_40298="Inverse psoriasis";
var content_f39_22_40298=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F79274%7EDERM%2F78531%7EDERM%2F76200%7EDERM%2F50615%7EOBGYN%2F56110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F79274%7EDERM%2F78531%7EDERM%2F76200%7EDERM%2F50615%7EOBGYN%2F56110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 217px; height: 145px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACRANkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5dtotxzjmtuzgPy+1VbGPgcf/AF62rKNuMqR/SuWpK5dOPVk8ECgcVZUHg9CKmjhGOeac0RUEnp29652dMY3Ks43R5BrLFuyXJIyQRWw8Jf1xVO4mWGXa3Jx+VHodVKLvZInhlZVAzk+ta1pOo9Olc1DKTKZMjpyK0YZVkiPGCT+VHIdqo23OpjnXy8qc461aivd5V04PfBrnLa5cDYAoBGAc1o2M8flt5q7ZcdfX3qHBmyo2V2a8iea/mEbz2pIPMEUqqDgc46HmqkN26tEu0N0JP9KuQNLPdsXbaSACo9MnAqWrESVkU79sfvIznYvzkdj2rc0u422x5IKk/jWVPErxXCoQoOc+5p2jORbr5h4DkEenvSsQuzOgUCRiG644NWYgTEDuG7PBqpFztYHkDHuams5PkKcEqcVLLLoQg8tx+VPGN23Ax2+tVxIpALg4zjBqRXJB5HHOPSkUStkJ0+tV5Ap69P0FPE3GfQdz2qq0isrlPuZ4pAO2D+Dbjt6VXlGMA5I6HmhpQp+XGB2qrJPubrnmmkDZHIQGbknHQjtUe4SD6UyWRgCeuDUYkUnGMZppEtk74AwGPTpVSU5XpzUhbHaonkGMZ5qkYykQOxCgA9+lZf8AZtr/AM+8f/fIq5I+wHpuqHf7t+darQ55PU4WxjJIGAAK2ooSAD2x+dVrGMDBI71swwgqueRWkmcEIi28Y25wfxqy8eRgjjFTRAKuGGDipFAfjOOKzZ0QRlMNoweB7VzmqoVnzztxXX3dqcbuM4rAv4TNGeBmnF63O7Dvllcx4mAHXNWUkcbMLuHrmo4bYMcN1Hepooi2Cei1vozvktTTjlwEYDHQHmr4cLEo6luc9azYLfdMW3sUxkgmrkeQ4JXgcjNQ0NdjXt8CMOYw/PTOMVfQiNWaaTYnUL3IHvWPDcFGXzAPkPHoafLI8vAclTzs5xismgltY0pZPtCBIMmMn+EdvelsVMZeM/dBzmsNbtok2E7C2Rgd60bCVlJddwjIGVY557UnHQlU03odHayIGjcdVBB5wKuRHe7EDa3UZ4zWTBLsUnZg4wQO4qfz45I/mYoAc471mRUjY09+VBU9D83HSmvLtPy4NZk11tJAQcjG4dx+dQibc6q0hbuFB+XGe9KxES5POViILkY6kDPHPFNguRtwiDB5wTVTUopvvrhhgEY7VXs5MQAvnknBotoacvu3LbzFmG7jnOKdLMoA2Hk9qpXBIkBX5gOMVD5wPJ/DFNIzloWzNhiGwAaY0yA/QVTkk+93PaovM3E85osZORbaU9CepqItwWbrnFRSvyGz07UiuArA9KpGEmRSuMtn8Kq+eabdNyfas7zB61qkc8paklpAVPT61q2wBB4psEBA+7VyKH5+nNDM4IXymyDwR2qZdkaEucA+gq3DEFQseVHtUkdsJm3Hr6DtWbZ0wiZ0kRZdyn5cdM1iSQFZHOBtOcc11NxbGNu+COB71mTwgx/L1IwRmhM6qcTlhEmXaM555xTxCM5AJI9KtrZrE7DPXnipYjtfHBzxz1rVS7HoqFyGJBkBkq9Dbq/zMxUAY49aZ8kmAxK464PWtSxiVQTlg2OCaq9yXCy0M1LF5bjuQMHBPb3p80PltsjB644Na8kWTmLeGJIbB7deKcbZthGQ69fw9/yosTDsznpbQLumkBDJyCOcCrtncbNu5xKoO4YwM/WpbuB2IQPmNh8wJxxVB7VlfdASAp5z3/Ck9TTlOjF1FKx3hQxXOVzj9KiW7gP7uLk9B6muaupLu0bzBI20jGwevakhmkDl2baSMMyjOPYVnyIxmmjpPN3ACUlT2GMjIpsEwR/3xGW4XK/4VFZzRNgJ8uWxuPQj1q5IrOWjYfumXO8DkmhLozO7SsWFkO3c2CwxmhY1IzIAD6VVsx5KYlztONu4nP0NWbu5XcFjPmYxk54rOwlsVbw7VYH+EYrN8wHIDH5eMVLdzhjtJIYnj3qrMp2ssYBwAeeKtIzmxksoycnnHGKBLtGOlV2yrcjHfikeQl89x60+U52y6JQzYB49aaznYSevQVSikKvgEYqRpM9afKZSkVr6T5Tg84rG88+v6Vd1OQBWAPtWD9oHpWsY3MHJI9JgiOPlb3NW4YivJU59qkt4RxgEAdauxRliByPWsmzanAkt48gAjjrxVyK1A+ZeD61PbRZU9CfarSKQTk8VmzaK6IzLiAMvzAkjmsi8tic5+7ndkDmuocKwPIyp59qz5rcMdvJJGetRc6qehxF4jJNtAG0+nNVHQKw8nJHfnpW5qtqYljb5VfPJbvVK3tll5cgtjp1rWEtD0oL3dCtbxK1wSOM4HNa726soVgfU571UuYXtnUgHy+vSr9v88RL7uP4c8gU+Ydu4y2kZWeNeg+7z2qzbTlNu4BSMbd3Oaowo7yuYm2leMGllmdYwsqAhuwGOa1izGdO+xNLavJKZNq84KjdjOT6VBN+6YbtpG7pnmm2UgZ4jnnIG3uMH8qfIgcZ3bgVOM8EEdzTauEGZl4kefldlYk5U9AKilt1iUrbhmOfvnhTW7BaxPaGVOSoOcnoc4/rWRdyS2oYjaVzzHjmoFJXJ7KR4WKMdrIv1BzVqDVJJJgGICrjHGMisK2E927K7qiN1CZI47ZqZ7WGNxGAyynkEHgigzklLodKl1HcSMAeD69KjuEieJkB2sOm08Z96xreSS3JR8A9wwwTTpb088bWxzkYPt7VKWolAdqKbyrQLkxvt2nuMdaghdyD7cYxziozdymTlcquQBmrkSk7HIA9TmqZjVSSsyKYZRiVB9CKz5yTlTwwrUuwAhEZCnuPWsu6+fGeMjsKSOGWhWSXD8kVYMmBg421WKjaWGDUE0jbAOlMxepS1WbAcA/lXPed9a072QsrHPOKxsn/JremrI5Kz1PoO1hXHfLH860kgGccDt9aLaJQytjJX9avJGTggHrnmuWx6cVqNih28r1FShMHLemamSPJ3Hg1KwBADAE/SpZqkUgijkrhj39qqlADjHB6HFaUkeUPy/SmSxnG1eGzyKhqx0Rlc4rX0klRYzGR07VnpG0ZQpzkcjHBrudSsA6bjlRXN3lrLAWWPkKucjtzRGVtDvo1YyjyozDcGddswyMgfMOT7UtvKQrbF+ZD90jmql7IQQ2394rZYjp+X41JYSPJG0uWVmOSfStbFW1siW4IkdAR5b9nIxRDcmbMcoyxGOePxq80QayO4AgDjPBFZF9FIHIjQkjkNxTTIbZKWVX8uWMiI4DY+Y+n9BUrLGyM6/NsUqOcE1Vjd5EKyS7GB4U4pxc4X7pP8RQ4P0q1IztrcuxRQraxhHZZIuQBxnjnjp3rD1oy+YT8mCTjC8lsc5rWe4RwrFPkHVc9M9qy9RAR1ntmyDldhbIwRimhSuZ9o9wpPlzMoZTuUrxgcfy71o2HmbsTRqQcqCh4z9aveGEs3k2tGsmVOQ4zjjp7H/Parmq2EWnsqRYCSMQoD7h0zQxRS7mQ5laRmyX2kmQ8cNnGePWoGmy/zjjv7U9ZxBcsJHySdrZGfxxVyKW3cmNxw/GccVDVgvbUpwRB4w65/DtzVvbuAZeP4SKG2WpKoQUY9hVuH7gBKnjOaV9TkrO7KDKVjG3kA/wAVU7hjjaRwPWtQxbRlumc1nXcZLA9ycCqTOKRnSDn5Tx6GqNyyltx7dq0GGODVG5CFue9M5+ph3qj5+eaya1rsFXbuKysV0R2OWqrs+oYUG7hR061fijyM9O9RwIvGSPpV9IwVwv0IrlsesmMji4CnqelOdAQARk8VNGm8kHj0pzqV6r81S0XcpMADk+2KYQDuPTvnFWP4ypA9vwqPDLIQQNp6+1RIuJTvGMhUL93NZ2pwo1u4287fTpWsYtrMTnGAOvA/zmq11ArRnb1KnPtUM3ptI821WHFxhc9Oo+h/wq3p6ER8YK7QCo7dv6ip57f/AE5gT93JAP0/z+dQnNsT5eDG4BGOMH1/OtU7o74yJ7dHmd4gR8uWG49R/nNV76PZEGyVkg6oOdw9vyNR3kkhujPbkhcZIJ/kO3WppXhubeNiA0gHI75x+tNGerKBVLmbfkbTnHU7gP69aiFmYWYHcc8gg8EfnUlxaSRIstmzsmMsuOh9RSxzMYnPR1zhGHDdMkenWqErXszNvpPI+6HAxhgOje9QmeOaAReWFbgqw7+1aMslvKpWdQvPAIzVFtOW3BbmSIdV/iU+3rVJmbT6DbBmgmBjfGQAygjnr1/MituKd7y2FtIEwh+VOgx7HrWVHDEcOsgaFiAHA5HrV77HPEjND++2/fCkEgdc+9JsFZakMenKJpAV2TA/LkndToIQ0TozYlUj5voOuKQy7wueXA4ZThgf8arebIuEDAuDncBz+P50XuHQe08kUhinXdtPLbcg+9aVgytGHJ4xn6VmTTyOp3R5OCAR61f09WNuoLfL02kdKTOerboWmPzqd25TziqtwgK469was4KcEcdqNgIww5FTc45GJPD1Iz+NZ1ynUFc4PWuiuI8rjnGKyLiMAN27VaOaZy97HgHAIrL8kf3jXSX8OdxwMYrK8j3P5VvB6HPON2fUCRhgc9R61bhwO4/GmQgHByOnarAjBYY6c/jWB6Nhdu4jBGM806X5eccZ5pyhQOex60Mu7d3FJlLQrPCpJx1zwB17Uzbkk47/AP1v61LICuTngHH1ppXA56Z/rUMtMqldxcZ+Xgj/AD+FZtzOsSbZOhyASM4/GtGVjGcgZAGSKzb+UGIInLSfLnqBnqay2NIs5+SNmvzKYThckdwxA9vSufvnSWeTYwAwG8vH3T3x7cV1217QLCy/KAdjdeM9K5y+s2W5hkACnBBU8E47H/GnGVmdVOfcyhJPAxYclQPmb1HpSCSNZxuLgliw29UPUHA7UpmZ9qMrL5b5Gcfrmpw2IP3jIVYAMF5YrxjHHB4rZM3i7lT7W5dghBYsRsHU57j29utRBllxHzHMpzx09KivVVEBd5FZhwcYJFU7xWBjZMuASyyk8/Q/57VVrmU076l61hNxI4lb95GcADjnsR35FaWmyxeb9lmUGXqOOfwFYpmVfLuXyJlwGdTlWX/H29jVstJcIssRBO4fMo5U98H/AD0pNDgvMnu7eA3W2ExoG4O08Ej/AB/nS20EsSFoWyy8bW6mq5cyMEnXZKi5+UfeHr7/AEq/HJA9splH7wE4IPX/AANJorljLczNStQsf2i2yXHLpnGPeqnzSIJGIDA4HvWpfEzsvl5Doeff6iqUg/0ZztK9iP7pprRC5XDYivZPLhA4BJwa0NFlMwKnhh39f84rnLtpQ2Ml1I6DtWxpDrCcE7W9wRj9Kco6GVdR5bs6FxvyW/Cq5ba5QnP49atrP50a+Uu4Ywdo/qaguIg5XcdhHIwKhHmzsynMxbqSVxWdNktnp61qupLZwP8AGs64UAkVaOeSMi6j+8TxWb5f+eK2LpAORVDy1/2qtGVrn0vHHtJYc4qdAQAM9vWol+U8Hv3qZFJTOc7sVJ3LzHx/dyQCM45FRzZVSEPNPUYxk9eR+JqMfKDk4PJ4FSy0iFzuBByT1xUUhbBHTjr1xU7LjJXuvINQsyhfmGc1ncbsVbmNQvQn3bmqaRAysTkqvygeh/yf0rRYZUlyOeMelZ0b446PknGO9RIcTP1a3klj+TKyIdwz04rFu0+0JkFuVJx2HTP/ANauqnVnVty57jPrXN3RkguQylk2NtckZGO39Ki5rfQ4+7jlhuSI2JSQYYk4LDPf6f4VcW5aGKOIFmQkFAjd/StLW7OVF89QjqDnK/4Vi20zwzCV49sTjsMk+4HPvxWibNIVHHXoPaGSXEc7KJOy9SBz3/KpZY4opFRlEgxht3JYe2KkTYquZUYM/ovBX0z/AFoXyZdrG1JweD93gfQGnzm6rRe5y9+Pss2xmZbdjtLHoD26flmrumK1pIglcqxGQp6ex/pWrqFjmLOxTG/8IAI/L+dUNOeWREgmiEnluVCk9s+vWq57o5nVUXoPkk+0IzKjKeSQOTken+e9JabpHUoF+cfL2zW9badBcK/2f93gZGV5BHUURaaRLgfMepVuDjPI/rS5zZVtblQWqO2GUqT90DnBHYHuParUulCWARpgkdeevsa2Y4V8qJXjypwQ4PJ+tQnTmSYybpiBwAf8aLtkSrs5H+wd10qopwTyRyBjrxWguhIoC7naQkfeONv4YrppLXdAPIBEg6lv4f60nkOgySCWOTn1qlJnNUqOe5zZ0ryxujcqw4wQMH9KY1uclWJD/XNdFNEDHkjCj0qhPCoGR+tFzBrQzZoiEC7sn6VnSjBOT061qSkrx1rNlQGRienfFUjCRl3C8EjFU/Kb+8v5VrXCDBwOapeU/wDdFaIwba2Pogna2TjpU0eTznr2FNwu3kcU9DtUZyOnTtUdT0FsK6n5wOp4FIG5G7qacpLNjPHao5Cw7EuBUspCfL5mAf4agkUc88cdDVhVyynGe1MkTcpI60mtAuUpFIUqeeKzY0LPzkELgHPeteRD5ZwM1QPyyAjjjBHp/nFZtDTKbSOq5xlh97jj/wCtVK8BFyruqmKT5HI6+1alySv3ADuPQmsyQbkIJGMksp7j/GoaKTuZM6+S0kTMv2ZhmP8A2fb+VUbSOCF2jkV87v3ZOSRxW5NEGh+RMlfmwfQ1jmRpJQrEB1XHA5wPWkiiRUdo3jtom4OGZuPyptpZwoglTcSTlkY4D9c49/rWvGjStG8Z2Jt2yKOCaqmzjW5XyASj7gDnow5/lQEUTQ2VvcRMbcnB6qMfyrEvNJ2XjmNNm7kY9fT9K2wjWkq3Ef3HbDYPf3/z2q3cxLIA33lB3dP5GhCfmYsDF9kc3Ew5EnTd+NTv5kU5DHDg5yR1Hp9adc2ktxE7lg7Bifl4zg8Ee9R2kfnNmVgRjr/eB4qkjSCTW5rQKWBIK7X7EVOYlQBWYsg53Dt9ay2aeJRgkq3Q98//AK61LeSQxMG6e1UiZQ0uEyHnaRtI7VVMZGQcdc1ZljkzlOO7Zqu+Sx3YyOx61aMXEglAGcke4rNuFHPB9K0pE79T1waoT4H3SBz0pozZkXK4BBGcdBWbOPmYgfWtm4C7j696zrhQct26VSMZIzJscnkmq3PtVmZcOB0BFVPI9qtGDPoWP/VN9RUy/db6UUUmdwqfcH1/oaSTt+H8hRRS6FCj/Vj8f5VG3b6UUVLJRB/C341mzf67/gX9DRRWUioEU3U/Wsm9/wBYPqf60UUpFx3Jbf8A49f+2Q/kK5n/AJikn0ooqUWdHb/6uH/dH8jRD/x/r/vn/wBF0UUiRB/yC5P+u/8A7PTbH/j3f6n+dFFAMfZ/db6f/E1lap/rovr/AFFFFUho0rj/AI9P+Af1FW7D/XT/AO6tFFWgZaf7q/739Kx737klFFV0M+oxu30FZN198UUURI6lJvvn6VSl6/jRRVmEtynP/B9D/Ss+iirjsc8tz//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inverse psoriasis of the axilla (armpit) is characterized by erythema without visible scaling.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James C Shaw, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined erythematous plaque is present in the inframammary area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous plaques involve the inguinal area in this patient with inverse psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, fissured plaque is present on the intergluteal skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 256px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Ridley, CM, Neill, SM (Eds), The Vulva, 2nd ed, Blackwell Science, Oxford 1999. Copyright &copy; 1999 Blackwell Science.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40298=[""].join("\n");
var outline_f39_22_40298=null;
var title_f39_22_40299="Causes of Budd Chiari syndrome";
var content_f39_22_40299=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of the Budd-Chiari syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Myeloproliferative diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatocellular carcinoma is most common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infections and benign lesions of the liver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral contraceptives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Hypercoagulable states",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Factor V Leiden mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Prothrombin gene mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Antiphospholipid antibody syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Antithrombin III deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Protein C deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Protein S deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Paroxysmal nocturnal hemoglobinuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        JAK2 mutations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Behcet's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Membranous webs of the inferior vena cava and/or the hepatic veins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miscellaneous conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Idiopathic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Many may have an underlying myeloproliferative disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40299=[""].join("\n");
var outline_f39_22_40299=null;
var title_f39_22_40300="Interactions between antiepileptic drugs and cytotoxic drugs";
var content_f39_22_40300=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F85983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F85983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interactions between antiepileptic drugs and cytotoxic drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        AED",
"       </td>",
"       <td class=\"subtitle1\">",
"        CTDs that decrease AED concentration",
"       </td>",
"       <td class=\"subtitle1\">",
"        CTDs that increase AED concentration",
"       </td>",
"       <td class=\"subtitle1\">",
"        CTDs whose concentrations are lowered by AED",
"       </td>",
"       <td class=\"subtitle1\">",
"        CTDs whose toxicity is increased by AED",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"       <td>",
"        <p>",
"         Nitrosourea",
"        </p>",
"        <p>",
"         Cisplatin",
"        </p>",
"        <p>",
"         Etoposide",
"        </p>",
"        <p>",
"         Dacarbazine",
"        </p>",
"        <p>",
"         Doxorubicin",
"        </p>",
"        <p>",
"         Carboplatin",
"        </p>",
"        <p>",
"         Vinblastine",
"        </p>",
"        <p>",
"         Methotrexate",
"        </p>",
"        <p>",
"         Bleomycin",
"        </p>",
"        Dexamethasone",
"       </td>",
"       <td>",
"        <p>",
"         5-FU",
"        </p>",
"        <p>",
"         Tegafur",
"        </p>",
"        <p>",
"         Tamoxifen",
"        </p>",
"        Dexamethasone",
"       </td>",
"       <td>",
"        <p>",
"         Busulfan",
"        </p>",
"        <p>",
"         Vincristine",
"        </p>",
"        <p>",
"         Methotrexate",
"        </p>",
"        <p>",
"         Paclitaxel",
"        </p>",
"        <p>",
"         Topotecan",
"        </p>",
"        <p>",
"         Irinotecan",
"        </p>",
"        <p>",
"         9-Aminocampthotecin",
"        </p>",
"        <p>",
"         Teniposide",
"        </p>",
"        Dexamethasone",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"       <td>",
"        <p>",
"         Cisplatin",
"        </p>",
"        Doxorubicin",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Vincristine",
"        </p>",
"        <p>",
"         Methotrexate",
"        </p>",
"        <p>",
"         Paclitaxel",
"        </p>",
"        <p>",
"         9-Aminocampthotecin",
"        </p>",
"        Teniposide",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valproic acid",
"       </td>",
"       <td>",
"        <p>",
"         Methotrexate",
"        </p>",
"        <p>",
"         Cisplatin",
"        </p>",
"        Doxorubicin",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Nitrosoureas",
"        </p>",
"        <p>",
"         Cisplatin",
"        </p>",
"        Etoposide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenobarbital",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Thiotepa",
"        </p>",
"        <p>",
"         Nitrosoureas",
"        </p>",
"        <p>",
"         Vincristine",
"        </p>",
"        <p>",
"         Methotrexate",
"        </p>",
"        <p>",
"         Paclitaxel",
"        </p>",
"        <p>",
"         9-Aminocampthotecin",
"        </p>",
"        <p>",
"         Teniposide",
"        </p>",
"        <p>",
"         Procarbazine",
"        </p>",
"        Prednisone",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AED: antiepileptic drugs; CTD: cytotoxic drugs.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: DeAngelis LM, Posner JB, Neurologic Complications of Cancer, 2nd, Oxford University Press, New York, 2009; by permission of Oxford Universtiy Press, Inc.",
"     <a href=\"file://www.oup.com\" style=\"FONT-STYLE: italic\" target=\"_blank\">",
"      www.oup.com",
"     </a>",
"     . Copyright &copy; 2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40300=[""].join("\n");
var outline_f39_22_40300=null;
var title_f39_22_40301="Incidence typhoid fever US";
var content_f39_22_40301=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reported incidence of typhoid fever and nontyphoidal salmonellosis in the United States, 1920 - 1995",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 229px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from R.V. Tauxe (Center for Disease Control and Prevention): Emerging Infectious Diseases, Volume 3 Number 4:425 - 34.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40301=[""].join("\n");
var outline_f39_22_40301=null;
var title_f39_22_40302="Occluded TIPS with fistula";
var content_f39_22_40302=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F77747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F77747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Occluded TIPS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Occlusion of a transjugular intrahepatic portosystemic shunt (TIPS) with a fistula between the stent and the biliary ducts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Arun Sanyal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40302=[""].join("\n");
var outline_f39_22_40302=null;
var title_f39_22_40303="Cystic hygroma CT I";
var content_f39_22_40303=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Patient with a known cystic hygroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An ectatic superior vena cava is seen on a contrast-enhanced CT scan.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_22_40303=[""].join("\n");
var outline_f39_22_40303=null;
